10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 10-Q

(Mark one)

☑  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: December 23, 2023

or

☐  Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to                  

Commission File Number: 000-03905         

TRANSCAT, INC.

(Exact name of registrant as specified in its charter)

Ohio	16-0874418
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

35 Vantage Point Drive, Rochester, New York 14624

(Address of principal executive offices) (Zip Code)

(585) 352-7777

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.50 par value	TRNS	Nasdaq Global Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☑
Non-accelerated filer ☐	Smaller reporting company ☐
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes No ☑

The number of shares of common stock, par value $0.50 per share, of the registrant outstanding as of January 26, 2024 was 8,829,127.

		Page(s)
PART I.	FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements:
	Statements of Income for the Third Quarter and Nine Months Ended December 23, 2023 and December 24, 2022	1
	Statements of Comprehensive Income for the Third Quarter and Nine Months Ended December 23, 2023 and December 24, 2022	2
	Balance Sheets as of December 23, 2023 and March 25, 2023	3
	Statements of Cash Flows for the Nine Months Ended December 23, 2023 and December 24, 2022	4
	Statements of Changes in Shareholders' Equity for the Third Quarter and Nine Months Ended December 23, 2023 and December 24, 2022	5
	Notes to Consolidated Financial Statements	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	33
Item 4.	Controls and Procedures	33
PART II.	OTHER INFORMATION
Item 6.	Exhibits	35
SIGNATURES		37

PART I. FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

	(Unaudited)						(Unaudited)
	Third Quarter Ended						Nine Months Ended
	December 23,			December 24,			December 23,			December 24,
	2023			2022			2023			2022
Service Revenue	$	41,509		$	35,977		$	122,793		$	105,120
Distribution Sales		23,657			21,425			65,775			63,382
Total Revenue		65,166			57,402			188,568			168,502
Cost of Service Revenue		28,015			25,184			82,244			72,005
Cost of Distribution Sales		16,215			15,818			46,553			47,292
Total Cost of Revenue		44,230			41,002			128,797			119,297
Gross Profit		20,936			16,400			59,771			49,205
Selling, Marketing and Warehouse Expenses		7,519			6,595			20,844			18,315
General and Administrative Expenses		9,123			6,642			28,350			20,497
Total Operating Expenses		16,642			13,237			49,194			38,812
Operating Income		4,294			3,163			10,577			10,393
Interest Expense		81			731			1,785			1,651
Interest Income		(347	)		(5	)		(347	)		(15	)
Other Income/Expense		289			313			304			96
Total Interest and Other		23			1,039			1,742			1,732
Income Before Income Taxes		4,271			2,124			8,835			8,661
Provision for Income Taxes		923			523			2,078			1,631
Net Income	$	3,348		$	1,601		$	6,757		$	7,030
Basic Earnings Per Share	$	0.39		$	0.21		$	0.84		$	0.93
Average Shares Outstanding		8,615			7,559			8,060			7,547
Diluted Earnings Per Share	$	0.38		$	0.21		$	0.83		$	0.92
Average Shares Outstanding		8,752			7,666			8,187			7,644

See accompanying notes to consolidated financial statements.

1

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

	(Unaudited)				(Unaudited)
	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Net Income	$	3,348	$	1,601	$	6,757	$	7,030
Other Comprehensive Income (Loss):
Currency Translation Adjustment		364		393		488		(878	)
Other, net of tax effects of $3 and $2 for the third quarter ended December 23, 2023 and December 24, 2022, respectively; and $7 and $(4) for the nine months ended December 23, 2023 and December 24, 2022, respectively		9		8		21		(12	)
Total Other Comprehensive Income (Loss)		373		401		509		(890	)
Comprehensive Income	$	3,721	$	2,002	$	7,266	$	6,140

See accompanying notes to consolidated financial statements.

2

TRANSCAT, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share and Per Share Amounts)

	(Unaudited)			(Audited)
	December 23,			March 25,
	2023			2023
ASSETS
Current Assets:
Cash and cash equivalents	$	35,205		$	1,531
Accounts Receivable, less allowance for credit losses of $579 and $457 as of December 23, 2023 and March 25, 2023, respectively		43,307			44,698
Other Receivables		819			506
Inventory, net		16,178			16,929
Prepaid Expenses and Other Current Assets		3,295			3,935
Total Current Assets		98,804			67,599
Property and Equipment, net		37,222			29,064
Goodwill		105,700			69,360
Intangible Assets, net		21,459			13,799
Right To Use Assets, net		16,834			14,876
Other Assets		1,055			1,051
Total Assets	$	281,074		$	195,749
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts Payable	$	11,355		$	15,869
Accrued Compensation and Other Current Liabilities		15,683			10,201
Current Portion of Long-Term Debt		2,316			2,248
Total Current Liabilities		29,354			28,318
Long-Term Debt		2,411			46,869
Deferred Tax Liabilities, net		10,855			6,538
Lease Liabilities		14,457			12,960
Other Liabilities		5,527			1,434
Total Liabilities		62,604			96,119
Shareholders' Equity:
Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 8,828,515 and 7,562,604 shares issued and outstanding as of December 23, 2023 and March 25, 2023, respectively		4,414			3,781
Capital in Excess of Par Value		140,382			27,886
Accumulated Other Comprehensive Loss		(691	)		(1,200	)
Retained Earnings		74,365			69,163
Total Shareholders' Equity		218,470			99,630
Total Liabilities and Shareholders' Equity	$	281,074		$	195,749

See accompanying notes to consolidated financial statements.

3

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

	(Unaudited)
	Nine Months Ended
	December 23,			December 24,
	2023			2022
Cash Flows from Operating Activities:
Net Income	$	6,757		$	7,030
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Net Loss on Disposal of Property and Equipment		24			62
Deferred Income Taxes		42			(52	)
Depreciation and Amortization		9,841			8,243
Provision for Accounts Receivable and Inventory Reserves		379			174
Stock-Based Compensation Expense		3,338			2,757
Changes in Assets and Liabilities, net of acquisitions:
Accounts Receivable and Other Receivables		3,819			1,850
Inventory		3,208			(3,589	)
Prepaid Expenses and Other Current Assets		728			1,074
Accounts Payable		(5,194	)		(424	)
Accrued Compensation and Other Current Liabilities		3,947			(3,150	)
Net Cash Provided by Operating Activities		26,889			13,975
Cash Flows from Investing Activities:
Purchases of Property and Equipment		(9,099	)		(7,149	)
Proceeds from Sale of Property and Equipment		-			10
Business Acquisitions, net of cash acquired		(12,932	)		(8,306	)
Net Cash Used in Investing Activities		(22,031	)		(15,445	)
Cash Flows from Financing Activities:
(Repayment of) Proceeds from Revolving Credit Facility, net		(42,713	)		2,286
Repayments of Term Loan		(1,678	)		(1,570	)
Issuance of Common Stock, net of direct costs		75,714			503
Repurchase of Common Stock		(2,247	)		(437	)
Net Cash Provided by Financing Activities		29,076			782
Effect of Exchange Rate Changes on Cash and cash equivalents		(260	)		885
Net Increase in Cash and cash equivalents		33,674			197
Cash and cash equivalents at Beginning of Period		1,531			1,396
Cash and cash equivalents at End of Period	$	35,205		$	1,593
Supplemental Disclosure of Cash Flow Activity:
Cash paid during the period for:
Interest	$	1,652		$	1,510
Income Taxes, net	$	1,884		$	957
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock issued for acquisitions	$	34,769		$	145
Assets acquired and liabilities assumed in business combinations:
Accrued holdback and contingent consideration related to acquisitions	$	4,859		$	518
Balance Sheet Reclassification of Property and Equipment, net to Inventory	$	737		$	576

See accompanying notes to consolidated financial statements.

4

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In Thousands, Except Par Value Amounts)

(Unaudited)

							Capital
	Common Stock						In			Accumulated
	Issued						Excess			Other
	$0.50 Par Value						of Par			Comprehensive			Retained
	Shares			Amount			Value			Income (Loss)			Earnings			Total
Balance as of March 26, 2022		7,529		$	3,765		$	23,900		$	(233	)	$	58,744		$	86,176
Issuance of Common Stock		8			3			363			-			-			366
Repurchase of Common Stock		(7	)		(3	)		(164	)		-			(270	)		(437	)
Stock-Based Compensation		16			8			820			-			-			828
Other Comprehensive Loss		-			-			-			(453	)		-			(453	)
Net Income		-			-			-			-			3,072			3,072
Balance as of June 25, 2022		7,546		$	3,773		$	24,919		$	(686	)	$	61,546		$	89,552
Issuance of Common Stock		3			2			141			-			-			143
Repurchase of Common Stock		-			-			-			-			-			-
Stock-Based Compensation		9			4			1,110			-			-			1,114
Other Comprehensive Loss		-			-			-			(838	)		-			(838	)
Net Income		-			-			-			-			2,357			2,357
Balance as of September 24, 2022		7,558		$	3,779		$	26,170		$	(1,524	)	$	63,903		$	92,328
Issuance of Common Stock		1			-			139			-			-			139
Stock-Based Compensation		1			1			814			-			-			815
Other Comprehensive Income		-			-			-			401			-			401
Net Income		-			-			-			-			1,601			1,601
Balance as of December 24, 2022		7,560		$	3,780		$	27,123		$	(1,123	)	$	65,504		$	95,284

							Capital
	Common Stock						In			Accumulated
	Issued						Excess			Other
	$0.50 Par Value						of Par			Comprehensive			Retained
	Shares			Amount			Value			Income (Loss)			Earnings			Total
Balance as of March 25, 2023		7,562		$	3,781		$	27,886		$	(1,200	)	$	69,163		$	99,630
Issuance of Common Stock		82			42			6,988			-			-			7,030
Repurchase of Common Stock		(3	)		(2	)		(86	)		-			(213	)		(301	)
Stock-Based Compensation		2			1			929			-			-			930
Other Comprehensive Income		-			-			-			482			-			482
Net Income		-			-			-			-			2,949			2,949
Balance as of June 24, 2023		7,643		$	3,822		$	35,717		$	(718	)	$	71,899		$	110,720
Issuance of Common Stock		313			156			27,967			-			-			28,123
Repurchase of Common Stock		(22	)		(11	)		(593	)		-			(1,342	)		(1,946	)
Stock-Based Compensation		44			22			1,219			-			-			1,241
Other Comprehensive Loss		-			-			-			(346	)		-			(346	)
Net Income		-			-			-			-			460			460
Balance as of September 23, 2023		7,978		$	3,989		$	64,310		$	(1,064	)	$	71,017		$	138,252
Proceeds from Issuance of Common Stock		849			424			80,229			-			-			80,653
Direct Costs of Stock Offering		-			-			(5,323	)		-			-			(5,323	)
Stock-Based Compensation		2			1			1,166			-			-			1,167
Other Comprehensive Income		-			-			-			373			-			373
Net Income		-			-			-			-			3,348			3,348
Balance as of December 23, 2023		8,829		$	4,414		$	140,382		$	(691	)	$	74,365		$	218,470

See accompanying notes to consolidated financial statements.

5

TRANSCAT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – GENERAL

Description of Business: Transcat, Inc. (“Transcat,” “we,” “us,” “our” or the “Company”) is a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor and rental source for professional grade handheld test, measurement and control instrumentation. The Company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly.

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 25, 2023 (“fiscal year 2023”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2023 filed with the SEC.

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with GAAP requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of major catalogs and intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

Revenue Recognition: Distribution non-rental sales are recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental sales are recognized over time using the output method-time elapsed as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the output method-time elapsed as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

Under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

6

 

Revenue recognized from prior period performance obligations for the third quarter of the fiscal year ending March 30, 2024 (“fiscal year 2024”) was immaterial. As of December 23, 2023, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of December 23, 2023 and March 25, 2023 were immaterial. See Note 4 for disaggregated revenue information.

Fair Value of Financial Instruments: Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to the variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs. At each of December 23, 2023 and March 25, 2023, investment assets totaled $0.2 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

Stock-Based Compensation: The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first nine months of fiscal year 2024 and fiscal year 2023, the Company recorded non-cash stock-based compensation cost of $3.3 million and $2.8 million, respectively, in the Consolidated Statements of Income.

Foreign Currency Translation and Transactions: The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in the local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.1 million for each of the first nine months of fiscal year 2024 and fiscal year 2023. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a loss of $0.1 million and a gain of $0.3 million during the first nine months of fiscal years 2024 and 2023, respectively, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On December 23, 2023, the Company had a foreign exchange contract, which matured in January 2024, outstanding in the notional amount of $2.0 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock units using the treasury stock method in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

7

 

For the third quarter of fiscal year 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. For the third quarter of fiscal year 2023, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share. For the first nine months of each of fiscal years 2024 and 2023, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Average Shares Outstanding – Basic		8,615		7,559		8,060		7,547
Effect of Dilutive Common Stock Equivalents		137		107		127		97
Average Shares Outstanding – Diluted		8,752		7,666		8,187		7,644
Anti-dilutive Common Stock Equivalents		37		148		46		163

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

	Goodwill						Intangible Assets
	Distribution		Service		Total		Distribution			Service			Total
Net Book Value as of March 25, 2023	$	11,458	$	57,902	$	69,360	$	448		$	13,351		$	13,799
Additions		26,707		9,416		36,123		7,900			3,983			11,883
Amortization		-		-		-		(910	)		(3,317	)		(4,227	)
Currency Translation Adjustment		-		217		217		-			4			4
Net Book Value as of December 23, 2023	$	38,165	$	67,535	$	105,700	$	7,438		$	14,021		$	21,459

8

 

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

	(Unaudited)		(Audited)
	December 23,		March 25,
	2023		2023
Current Liabilities:
Accrued Payroll and Employee Benefits	$	4,056	$	3,243
Accrued Incentives		3,095		2,507
Current Portion of Lease Liabilities		2,878		2,333
Accrued Acquisition Holdbacks		2,749		252
Accrued Contingent Consideration		1,029		-
Other Current Liabilities		1,876		1,866
Accrued Compensation and Other Current Liabilities	$	15,683	$	10,201
Non-Current Liabilities:
Postretirement Benefit Obligation	$	1,238	$	1,266
Accrued Acquisition Holdbacks		1,647		-
Accrued Contingent Consideration		2,402		-
Other Non-Current Liabilities		240		168
Other Liabilities	$	5,527	$	1,434

Recently Adopted Accounting Pronouncements: In June 2016, the Financial Accounting Standard Board (“FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The ASU replaces the "incurred loss" model with an "expected credit loss" model that requires entities to estimate an expected lifetime credit loss on financial assets, including trade accounts receivable. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Allowance for credit losses for accounts receivable is the most significant item for the Company under this ASU. The Company adopted ASU 2016-13 effective on March 26, 2023.  The adoption of this standard did not have a material impact on our consolidated financial statements.

9

NOTE 2 – LONG-TERM DEBT

On July 7, 2021, the Company entered into the Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), that amended and restated in its entirety the Company’s prior credit agreement with M&T.

The Credit Agreement provides for a revolving credit commitment (the “Revolving Credit Commitment”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million.  The Company's 2018 term loan, with an original principal amount of $15.0 million (the "2018 Term Loan"), is also provided for under the Credit Agreement.

The Credit Agreement allows the Company to use up to $50.0 million under the Revolving Credit Commitment for acquisitions in any single fiscal year.  The Credit Agreement restricts the Company's ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the Revolving Credit Commitment.

Under the Credit Agreement, the Company may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

As of December 23, 2023, $80.0 million was available for borrowing under the revolving credit facility.  As of December 23, 2023, there were no amounts outstanding under the revolving credit facility. During the first nine months of fiscal year 2024, $12.9 million was drawn from the revolving credit facility and used for business acquisitions.

As of December 23, 2023, $4.7 million was outstanding on the 2018 Term Loan, of which $2.3 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total amortizing repayments (principal plus interest) of $0.2 million per month through its maturity date in December 2025.

Interest and Other Costs: Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at Transcat’s election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin.  Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon the Company’s calculated leverage ratio. The Company’s interest rate for the revolving credit facility for the first nine months of fiscal year 2024 ranged from 6.4% to 7.1%.  Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

Covenants: The Credit Agreement has certain covenants with which the Company must comply, including a fixed charge ratio covenant, which prohibits the Company's fixed charge ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits the Company's leverage ratio from exceeding 3.00 to 1.00. The Company was in compliance with all loan covenants and requirements during the first nine months of fiscal year 2024. The Company's leverage ratio, as defined in the Credit Agreement, was 0.12 at December 23, 2023, compared with 1.60 at March 25, 2023.

Other Terms: The Company has pledged all of its U.S. tangible and intangible personal property, the equity interests of its U.S.-based subsidiaries, and a majority of the common stock of Transcat Canada Inc. as collateral security for the loans made under the revolving credit facility.

10

NOTE 3 – STOCK-BASED COMPENSATION

In September 2021, the Transcat, Inc. 2021 Stock Incentive Plan (the “2021 Plan”) was approved by shareholders and became effective. The 2021 Plan replaced the Transcat, Inc. 2003 Incentive Plan (the “2003 Plan”). Shares available for grant under the 2021 Plan include any shares remaining available for issuance under the 2003 Plan and any shares that are subject to outstanding awards under the 2003 Plan that are subsequently canceled, expired, forfeited, or otherwise not issued or are settled in cash. The 2021 Plan provides for, among other awards, grants of restricted stock units and stock options to directors, officers and key employees at the fair market value at the date of grant. At December 23, 2023, 0.6 million shares of common stock were available for future grant under the 2021 Plan.

The Company receives an excess tax benefit related to restricted stock vesting and stock options exercised and redeemed. The discrete tax benefits related to share-based compensation and stock option activity during the first nine months of fiscal year 2024 and fiscal year 2023 were $0.7 million and $0.5 million, respectively.

Restricted Stock Units: The Company grants time-based and performance-based restricted stock units as a component of executive and key employee compensation. Expense for restricted stock unit grants is recognized on a straight-line basis for the service period of the stock award based upon fair value of the award on the date of grant. The fair value of the restricted stock unit grants is the quoted market price for the Company’s common stock on the date of grant. These restricted stock units are either time vested, or vest following the third fiscal year from the date of grant subject to cumulative diluted earnings per share or cumulative adjusted EBITDA targets over the eligible period.

Compensation cost ultimately recognized for performance-based restricted stock units will equal the grant date fair market value of the unit that coincides with the actual outcome of the performance conditions. On an interim basis, the Company records compensation cost based on the estimated level of achievement of the performance conditions. The expense relating to the time vested restricted stock units is recognized on a straight-line basis over the requisite service period for the entire award.

The following table summarizes the non-vested restricted stock units outstanding as of December 23, 2023 (in thousands, except per unit data):

		Total	Grant Date		Estimated
		Number	Fair		Level of
Date	Measurement	of Units	Value		Achievement at
Granted	Period	Outstanding	Per Unit		December 23, 2023
October 2018	October 2018 – September 2028	6	$	20.81	Time Vested
June 2021	June 2021 – March 2024	10	$	53.17	136% of target level
June 2021	June 2021 – March 2024	11	$	53.17	Time Vested
September 2021	September 2021 – September 2024	4	$	67.76	Time Vested
January 2022	January 2022 – March 2024	1	$	90.92	136% of target level
January 2022	January 2022 – March 2024	1	$	90.92	Time Vested
January 2022	January 2022 – January 2025	1	$	90.41	Time Vested
March 2022	March 2022 – March 2025	1	$	76.31	Time Vested
May 2022	May 2022 – March 2025	11	$	63.17	64% of target level
May 2022	May 2022 – March 2025	12	$	63.17	Time Vested
August 2022	August 2022 – August 2025	1	$	78.04	Time Vested
December 2022	December 2022 – December 2025	1	$	81.26	Time Vested
December 2022	December 2022 – December 2025	1	$	67.48	Time Vested
May 2023	May 2023 – March 2026	10	$	89.70	150% of target level
May 2023	May 2023 – March 2026	11	$	89.70	Time Vested
May 2023	May 2023 – May 2026	19	$	89.70	Time Vested
August 2023	August 2023 – August 2024	6	$	90.56	Time Vested
September 2023	September 2023 – September 2024	4	$	109.55	Time Vested

11

 

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $2.4 million and $1.7 million in the first nine months of fiscal year 2024 and fiscal year 2023, respectively. As of December 23, 2023, unearned compensation, to be recognized over the grants’ respective service periods, totaled $4.4 million.

Stock Options: The Company grants stock options to employees and directors with an exercise price equal to the quoted market price of the Company’s stock at the date of the grant. The fair value of stock options is estimated using the Black-Scholes option pricing formula that requires assumptions for expected volatility, expected dividends, the risk-free interest rate and the expected term of the option. Expense for stock options is recognized on a straight-line basis over the requisite service period for each award. Options vest either immediately or over a period of up to five years using a straight-line basis and expire either five years or ten years from the date of grant.

We calculate the fair value of the stock options granted using the Black-Scholes model. The following weighted-average assumptions were used to value options granted during the first three and nine months of fiscal year 2024 and fiscal year 2023:

	Third Quarter Ended					Nine Months Ended
	December 23,			December 24,		December 23,			December 24,
	2023			2022		2023			2022
Risk-Free Interest Rate		4.84	%		N/A		4.09	%		2.65	%
Volatility Factor		37.31	%		N/A		37.12	%		37.62	%
Expected Term (in Years)		6.50			N/A		6.30			4.58
Annual Dividend Rate		0.00	%		N/A		0.00	%		0.00	%

We calculate expected volatility for stock options by taking an average of historical volatility over the expected term. The computation of expected term was determined based on safe harbor rules, giving consideration to the contractual terms of the stock-based awards and vesting schedules. The interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield in effect at the time of grant. We assume no expected dividends. Under FASB ASC Topic 718, “Compensation – Stock Compensation”, the Company has elected to account for forfeitures as they occur.

During the first nine months of fiscal year 2024, the Company granted options for 7,000 shares of common stock in the aggregate to Company employees that vest over three years, an option for 10,000 shares of common stock to a Company employee that vests over five years and options for 20,000 shares of common stock (10,000 each) to two Company directors that vest over five years.

During the first nine months of fiscal year 2023, the Company granted options for 46,000 shares of common stock in the aggregate to Company employees that vest over three years and an option for 10,000 shares of common stock to a Company director that vests over five years.

The expense related to all stock option awards was $0.9 million in the first nine months of fiscal year 2024 and $1.1 million in the first nine months of fiscal year 2023.

12

 

The following table summarizes the Company’s options as of and for the first nine months ended December 23, 2023 (in thousands, except price per option data and years):

				Weighted		Weighted
				Average		Average
	Number			Exercise		Remaining		Aggregate
	Of			Price Per		Contractual		Intrinsic
	Options			Option		Term (in years)		Value
Outstanding as of March 25, 2023		217		$	56.25
Granted		37		$	93.18
Exercised		(4	)	$	24.30
Forfeited		(5	)	$	68.13
Outstanding as of December 23, 2023		245		$	62.06		6	$	11,180
Exercisable as of December 23, 2023		82		$	41.17		6	$	4,984

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the third quarter of fiscal year 2024 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on December 23, 2023. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

Total unrecognized compensation cost related to non-vested stock options as of December 23, 2023 was $2.4 million, which is expected to be recognized over a period of three years. The aggregate intrinsic value of stock options exercised during the first nine months of fiscal year 2024 was $0.3 million and during the first nine months of fiscal year 2023 was $0.2 million. Cash received from the exercise of options in the first nine months of fiscal year 2024 and fiscal year 2023 was $0.1 million and less than $0.1 million, respectively.

13

NOTE 4 – SEGMENT INFORMATION

The basis for determining our operating segments is the manner in which financial information is used in monitoring our operations. Transcat has two reportable segments: Service and Distribution. Through our Service segment, we offer calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Through our Distribution segment, we sell and rent national and proprietary brand instruments to customers globally. The Company has no inter-segment sales. We believe that reporting performance at the operating income level is the best indicator of segment performance. The following table presents segment and geographic data for the third quarter and first nine months of fiscal year 2024 and fiscal year 2023 (dollars in thousands):

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Revenue:
Service	$	41,509	$	35,977	$	122,793	$	105,120
Distribution		23,657		21,425		65,775		63,382
Total		65,166		57,402		188,568		168,502
Gross Profit:
Service		13,494		10,793		40,549		33,115
Distribution		7,442		5,607		19,222		16,090
Total		20,936		16,400		59,771		49,205
Operating Expenses:
Service (1)		10,528		8,957		33,649		26,240
Distribution (1)		6,114		4,280		15,545		12,572
Total		16,642		13,237		49,194		38,812
Operating Income:
Service		2,966		1,836		6,900		6,875
Distribution		1,328		1,327		3,677		3,518
Total		4,294		3,163		10,577		10,393
Unallocated Amounts:
Interest and Other Expense, net		23		1,039		1,742		1,732
Provision for Income Taxes		923		523		2,078		1,631
Total		946		1,562		3,820		3,363
Net Income	$	3,348	$	1,601	$	6,757	$	7,030
Geographic Data:
Revenues to Unaffiliated Customers (2)
United States (3)	$	59,090	$	51,209	$	170,466	$	151,241
Canada		4,083		4,221		12,226		12,075
Other International		1,993		1,972		5,876		5,186
Total	$	65,166	$	57,402	$	188,568	$	168,502

⁽¹⁾ Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.

⁽²⁾ Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

⁽³⁾ United States includes Puerto Rico.

14

NOTE 5 – BUSINESS ACQUISITIONS

Axiom: Effective August 8, 2023, Transcat purchased all of the outstanding capital stock of Axiom Test Equipment, Inc. (“Axiom”), a privately-held California rental provider of electronic test equipment to customers across the United States. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Distribution capabilities.

The Axiom goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Axiom acquisition has been allocated to the Distribution segment. Intangible assets related to the Axiom acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to twelve years and are not deductible for tax purposes. Amortization of goodwill related to the Axiom acquisition is not deductible for tax purposes.

The total purchase price for Axiom was approximately $38.6 million and was paid with $10.0 million in cash and the issuance of our common stock valued at $28.6 million. Pursuant to the asset purchase agreement, the Company held back approximately $3.9 million of the purchase price for certain potential post-closing adjustments.

The purchase price allocation is subject to revision based upon our final review of tangible and intangible asset valuation assumptions, working capital adjustments, assets acquired, and liabilities assumed. The amount of goodwill changed since September 23, 2023 due to the finalization of inventory and property and equipment values.  The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Axiom's assets and liabilities acquired on August 8, 2023 (in thousands):

Goodwill		$	26,707
Intangible Assets – Customer Base & Contracts			7,900
			34,607
Plus:	Cash		37
	Accounts Receivable		962
	Inventory		1,796
	Other Current Assets		84
	Property and Equipment		4,965
Less:	Current Liabilities		(631	)
	Deferred Tax Liability		(3,256	)
Total Purchase Price		$	38,564

From the date of acquisition through the end of the third quarter of fiscal year 2024, Axiom has contributed revenue of $4.3 million and operating income of $0.4 million, which includes the negative impact of amortization of the acquired intangible assets.

SteriQual: Effective July 12, 2023, Transcat purchased all of the outstanding capital stock of SteriQual, Inc. (“SteriQual”), a Florida based provider of expert consulting services to pharmaceutical, biopharmaceutical, medical device and diagnostic equipment manufacturers. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The SteriQual goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the SteriQual acquisition has been allocated to the Service segment. Intangible assets related to the SteriQual acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the SteriQual acquisition is not deductible for tax purposes.

The total purchase price for SteriQual was approximately $4.3 million and was paid by the issuance of our common stock.  Pursuant to the asset purchase agreement, the Company held back approximately $0.9 million of the purchase price for certain potential post-closing adjustments. Pursuant to the asset purchase agreement, the purchase price is subject to reduction by $0.5 million if certain revenue targets are not met through July 12, 2024. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. The purchase price was reduced to $3.8 million as of December 23, 2023 as the Company recorded a receivable in the amount of $0.5 million related to the revenue target contingent consideration. This receivable was recognized based on the facts and circumstances at the date of acquisition and is recognized as a component of goodwill and not recorded in the Consolidated Statement of Income. 

15

The purchase price allocation is subject to revision based upon our final review of intangible asset valuation assumptions, working capital adjustments, assets acquired, and liabilities assumed. The amount of goodwill changed since September 23, 2023 due to the accounts receivable balance as part of the contingent consideration.  The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of SteriQual's assets and liabilities acquired on July 12, 2023 (in thousands):

Goodwill		$	2,163
Intangible Assets – Customer Base & Contracts			1,062
Intangible Assets – Covenant Not to Compete			392
Intangible Assets – Sales Backlog			95
			3,712
Plus:	Accounts Receivable		666
Less:	Current Liabilities		(211	)
	Deferred Tax Liability		(383	)
Total Purchase Price		$	3,784

From the date of acquisition through the end of the third quarter of fiscal year 2024, SteriQual has contributed revenue of $1.9 million and operating income of less than $0.1 million, which includes the negative impact of amortization of the acquired intangible assets.

TIC-MS: Effective March 27, 2023, Transcat purchased all of the outstanding capital stock of TIC-MS, Inc. (“TIC-MS”), a Missouri based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The TIC-MS goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the TIC-MS acquisition has been allocated to the Service segment. Intangible assets related to the TIC-MS acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the TIC-MS acquisition is not deductible for tax purposes.

The total purchase price for TIC-MS was approximately $9.8 million and was paid with $2.9 million in cash, including $0.5 million placed in escrow for contingent consideration, certain post-closing adjustments and indemnification claims, if any, and the issuance of 77,387 shares of our common stock valued at $6.9 million. Pursuant to the asset purchase agreement, the purchase price will be subject to reduction by up to $0.5 million if a key customer relationship is not retained through March 27, 2024. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. As of December 23, 2023, we continued to retain this key customer relationship. As a result, there has not been a receivable recognized relating to the $0.5 million contingent consideration.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of TIC-MS's assets and liabilities acquired on March 27, 2023 (in thousands):

Goodwill		$	7,253
Intangible Assets – Customer Base & Contracts			2,303
Intangible Assets – Covenant Not to Compete			132
			9,688
Plus:	Accounts Receivable		499
	Property and Equipment		356
Less:	Current Liabilities		(128	)
	Deferred Tax Liability		(636	)
Total Purchase Price		$	9,779

From the date of acquisition through the end of the third quarter of fiscal year 2024, TIC-MS has contributed revenue of $2.7 million and operating income of $1.1 million, which includes the negative impact of amortization of the acquired intangible assets.

16

 

Elite: Effective February 2, 2023, Transcat acquired substantially all of the assets of Elite Calibration LLC (“Elite”), a California based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that can leverage the Company’s already existing operating infrastructure.

All the goodwill related to the Elite acquisition has been allocated to the Service segment. Amortization of goodwill related to the Elite acquisition is deductible for tax purposes.  The goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition.

The total purchase price for the assets of Elite was approximately $0.9 million, of which $0.8 million was paid in cash. Pursuant to the asset purchase agreement, the Company held back $0.1 million of the purchase price for certain potential post-closing adjustments.  As of December 23, 2023, no amounts have been paid.  The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Elite’s assets and liabilities acquired on February 2, 2023 (in thousands):

Goodwill		$	820
Plus:	Accounts Receivable		62
Total Purchase Price		$	882

Since this operation was integrated immediately into our existing operations, its separate contributed revenue and operating income is undeterminable.

Complete Calibrations: Effective September 28, 2022, Transcat purchased all of the outstanding capital stock of Galium Limited (d/b/a Complete Calibrations) ("Complete Calibrations"), an Irish company.  This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities. 

All the goodwill related to the Complete Calibrations acquisition has been allocated to the Service segment. Amortization of goodwill related to the Complete Calibrations acquisition is not deductible for tax purposes.  The goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition.

The total purchase price paid for Complete Calibrations was approximately $1.2 million in cash.  In connection with this transaction, the Company also entered into a Technology License Agreement with Calibration Robots Limited, an Irish company and related party to Complete Calibrations, for the use of their proprietary robotics in completing calibrations.  The Technology License Agreement includes transactional royalties in the amount of 3 Euros ($3.19) per calibration performed by technology covered under this license agreement, with a royalty term of up to ten years commencing from the earlier of (i) the date on which cumulative revenue earned from technology covered under this license agreement equals 0.75 million Euros ($0.80 million), and (ii) March 28, 2024.  In addition to the transactional royalties, as long as a key employee is employed by the Company, there is an annual royalty fee of 0.1 million Euros ($0.11 million).  For purposes of this paragraph, we used a conversion rate of 1.1014 to convert Euro to U.S. dollar as of December 23, 2023.  As of December 23, 2023, the key employee is still employed by the Company.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Complete Calibrations’ assets and liabilities acquired on September 28, 2022 (in thousands):

Goodwill		$	1,123
Plus:	Cash		10
	Inventory		44
Total Purchase Price		$	1,177

During the first nine months of fiscal year 2024, Complete Calibrations has contributed revenue of $0.3 million and operating loss of less than $0.1 million.

17

 

e2b: Effective September 27, 2022, Transcat acquired substantially all of the assets of e2b Calibration (“e2b”), an Ohio based provider of calibration services.  This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities. 

The e2b goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the e2b acquisition has been allocated to the Service segment. Intangible assets related to the e2b acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are deductible for tax purposes. Amortization of goodwill related to the e2b acquisition is deductible for tax purposes.

The total purchase price paid for the assets of e2b was approximately $3.1 million in cash.  Pursuant to the asset purchase agreement, the Company held back $0.9 million of the purchase price in escrow for certain potential post-closing adjustments.  During the third quarter of fiscal year 2023, $0.6 million of the escrow was released to the sellers.  During the third quarter of fiscal year 2024, $0.3 million was released to the sellers.  As of December 23, 2023, there is no money remaining in escrow.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of e2b’s assets and liabilities acquired on September 27, 2022 (in thousands):

Goodwill		$	1,367
Intangible Assets – Customer Base & Contracts			746
Intangible Assets – Covenant Not to Compete			396
			2,509
Plus:	Accounts Receivable		361
	Other Current Assets		24
	Property and Equipment		326
Less:	Current Liabilities		(121	)
Total Purchase Price		$	3,099

 

During the first nine months of fiscal year 2024, e2b has contributed revenue of $2.6 million and operating income of $0.4 million, which includes the negative impact of amortization of the acquired intangible assets.

Alliance: Effective May 31, 2022, Transcat acquired substantially all of the assets of Charlton Jeffmont Inc., Raitz Inc. and Toolroom Calibration Inc. d/b/a Alliance Calibration (“Alliance”), an Ohio based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The Alliance goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Alliance acquisition has been allocated to the Service segment. Intangible assets related to the Alliance acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are deductible for tax purposes. Amortization of goodwill related to the Alliance acquisition is deductible for tax purposes.

The purchase price for Alliance was approximately $4.7 million and was paid with $4.0 million in cash and the issuance of 2,284 shares of our common stock valued at $0.1 million. Pursuant to the asset purchase agreement, the Company held back $0.5 million of the purchase price for certain potential post-closing adjustments, and the purchase price would have been subject to reduction by $0.5 million if a key customer relationship was not retained. During the first quarter of fiscal year 2024, $0.5 million of the holdback was released to the sellers.

18

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Alliance’s assets and liabilities acquired on May 31, 2022 (in thousands):

Goodwill		$	1,783
Intangible Assets – Customer Base & Contracts			2,320
Intangible Assets – Covenant Not to Compete			114
			4,217
Plus:	Accounts Receivable		343
	Property and Equipment		170
Less:	Current Liabilities		(27	)
Total Purchase Price		$	4,703

During the first nine months of fiscal year 2024, Alliance has contributed revenue of $2.0 million and operating income of $0.6 million, which includes the negative impact of amortization of the acquired intangible assets.

NEXA: Effective August 31, 2021, Transcat purchased all of the outstanding capital stock of Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management), an Irish company, which owns all of the issued and outstanding capital stock of its U.S.-based subsidiary, Cal OpEx Inc., a Delaware corporation (collectively, “NEXA”). On September 11, 2023, the Company entered into an amendment (the “Amendment”) to a Share Purchase Agreement dated August 31, 2021 (the “Purchase Agreement”) with John Cummins and Ross Lane (the “Sellers”) associated with the Company’s purchase of all of the outstanding capital stock of NEXA. As described below, the Amendment changes the conditions necessary for the Sellers to receive potential earn-out payments, changes the lines of business included in the calculation of earnings before income taxes, depreciation and amortization (“EBITDA”), and changes the outside due date of any potential earn-out payments.

Pursuant to the Purchase Agreement, the Sellers were entitled to potential earn-out payments in an aggregate amount of up to $7.5 million for the calendar years ending December 31, 2022, 2023, 2024, and 2025 (each, an “Earn-Out Year”) if NEXA’s consolidated gross revenue, as defined in the Purchase Agreement, equaled or exceeded 70% of the target revenue specified in the Purchase Agreement and NEXA’s consolidated EBITDA percentage, as defined in the Purchase Agreement, equaled or exceeded 25% for a given earn-out year. The potential earn-out payment of up to $0.4 million for the 2022 Earn-Out Year was not earned under the Purchase Agreement.

Pursuant to the Amendment, the Sellers are now entitled to potential earn-out payments in an aggregate amount of up to $7.1 million for the remaining Earn-Out Years (2023, 2024 and 2025) if NEXA’s consolidated EBITDA, as defined in the Amendment, equals or exceeds 70% of the target EBITDA specified in the Amendment for a given earn-out year. Pursuant to the Amendment, the definition of EBITDA was revised to include EBITDA from the Commissioning, Qualification and Validation business ("CQV") and incremental EBITDA from the SteriQual, Inc. business. The maximum earn-out payment will be received if NEXA’s consolidated EBITDA equals or exceeds 150% of the target EBITDA specified in the Amendment. The earn-out payments, if any, will be paid in shares of common stock, calculated using the volume-weighted average closing price of the common stock for 30 consecutive trading days ending on the trading day that is two days prior to the date the earn-out payment is to be paid (“VWAP”). If the VWAP is less than $45.07 per share, then the Company may pay the earn-out payment in cash in lieu of shares of common stock.

As of March 25, 2023, the estimated fair value for the total earn-out obligations under the Purchase Agreement, classified as Level 3 in the fair value hierarchy, was zero. As of September 23, 2023, the estimated fair value for the total earn-out obligations under the Amendment, classified as Level 3 in the fair value hierarchy, was approximately $2.8 million. This amount was calculated using a Geometric Brownian motion distribution that was then used in a Monte Carlo simulation model. Assumptions used in the Monte Carlo simulation model included: 1) discount rate of 9.00%, 2) risk-free interest rate of 5.00%, 3) asset volatility of 25.00%, and 4) forecasted revenue and EBITDA. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. Due to the uncertainty with utilizing these significant unobservable inputs for this Level 3 fair value measurement, materially higher or lower fair value measurements may be recognized at subsequent remeasurement periods. The Company recognized a non-cash expense of $2.8 million, which was recorded in general and administrative expenses in its Consolidated Statement of Income for the quarter ended  September 23, 2023.  As of December 23, 2023, the estimated fair value of the total earn-out obligations under the Amendment was approximately $2.9 million.  The change in accrual is due to the actual results of the 2023 calendar Earn-Out Year and the accretion of the 2024 and 2025 Earn-Out Years.  As a result, the Company recognized a non-cash expense of $0.1 million, which was recorded in general and administrative expenses in its Consolidated Statement of Income for the quarter ended December 23, 2023.  There were no material changes in assumptions that would impact the valuation as of December 23, 2023.

19

 

The results of acquired businesses are included in Transcat’s consolidated operating results as of the dates the businesses were acquired. The following unaudited pro forma information presents the Company’s results of operations as if the acquisitions of Axiom, SteriQual, TIC-MS, Elite, Complete Calibrations, e2b and Alliance had occurred at the beginning of fiscal year 2023. The pro forma results do not purport to represent what the Company’s results of operations actually would have been if the transactions had occurred at the beginning of the period presented or what the Company’s operating results will be in future periods.

	(Unaudited)				(Unaudited)
	Third Quarter Ended				Nine Months Ended
(in thousands except per share information)	December 23, 2023		December 24, 2022		December 23, 2023		December 24, 2022
Total Revenue	$	65,166	$	62,868	$	192,613	$	186,276
Net Income	$	3,348	$	1,383	$	6,548	$	5,801
Basic Earnings Per Share	$	0.39	$	0.18	$	0.81	$	0.77
Diluted Earnings Per Share	$	0.38	$	0.18	$	0.80	$	0.76

Certain of the Company’s acquisition agreements include provisions for contingent consideration and other holdback amounts. The Company accrues for contingent consideration and holdback provisions based on their estimated fair value at the date of acquisition and at subsequent remeasurement periods, as applicable.  As of December 23, 2023, $1.0 million contingent consideration and $2.7 million of other holdback amounts unpaid are reflected in current liabilities on the Consolidated Balance Sheets and $2.4 million of contingent consideration and $1.6 million of other holdback amounts unpaid are reflected in other liabilities on the Consolidated Balance Sheets. During the first nine months of fiscal year 2024, $0.8 million of holdback amounts were paid.  During the first nine months of fiscal year 2023, no contingent consideration or other holdback amounts were paid.

During the first nine months of fiscal year 2024 and fiscal year 2023, acquisition costs of $0.7 million and $0.1 million, respectively, were recorded as incurred as general and administrative expenses in the Consolidated Statements of Income.

NOTE 6 – STOCK OFFERING

On September 21, 2023, the Company entered into an underwriting agreement with Oppenheimer & Co. Inc., as representative of several underwriters, for the sale of common stock in an underwritten public offering at a public offering price of $95.00 per share (the “Offering”). The Offering closed on September 25, 2023 and the Company sold an aggregate of 847,371 shares in the Offering, which included 110,526 shares issued upon the exercise by the underwriters of their over-allotment option, for total gross proceeds of $80.5 million. Net proceeds received after direct costs in the Offering were $75.2 million. A portion of the net proceeds from this Offering were used to pay off the Revolving Credit Facility in full.

20

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements. This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations, estimates, beliefs, assumptions and predictions of future events and are identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “potential,” “outlook,” “seek,” “strategy,” “target,” “could,” “may,” “will,” “would,” and other similar words. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical results or those expressed in such forward-looking statements. You should evaluate forward-looking statements in light of important risk factors and uncertainties that may affect our operating and financial results and our ability to achieve our financial objectives. These factors include, but are not limited to, general economic conditions applicable to our business, inflationary impacts, the impact of widespread public health crises, the highly competitive nature of the industries in which we compete and in the nature of our two business segments, the concentration of Service segment customers in the life science and other FDA-regulated and industrial manufacturing industries, the significant competition we face in our Distribution segment, any impairment of our goodwill or intangible assets, tariffs and trade relations, our ability to successfully complete and integrate business acquisitions, cybersecurity risks, the risk of significant disruptions in our information technology systems, our ability to recruit, train and retain quality employees, skilled technicians and senior management, fluctuations in our operating results, our ability to achieve or maintain adequate utilization and pricing rates for our technical service providers, the prices we are able to charge for our services in our Service segment, competition in the rental market, our ability to adapt our technology, reliance on our enterprise resource planning system, technology updates, supply chain delays or disruptions, the risks related to current and future indebtedness, foreign currency rate fluctuations, risks related to our intellectual property, geopolitical events, adverse weather events or other catastrophes or natural disasters, the volatility of our stock price, the relatively low trading volume of our common stock, changes in tax rates, changes in accounting standards, legal requirements and listing standards, and legal and regulatory risks related to our international operations. These risk factors and uncertainties are more fully described by us under the heading “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended March 25, 2023. You should not place undue reliance on our forward-looking statements, which speak only as of the date they are made. Except as required by law, we undertake no obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this report, whether as a result of new information, future events or otherwise.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

There have been no material changes to our critical accounting policies and estimates from the information provided in our Annual Report on Form 10-K for the fiscal year ended March 25, 2023.

RESULTS OF OPERATIONS

Recent Developments

On September 25, 2023, we closed an underwritten public offering of our common stock for aggregate gross proceeds of $80.5 million (the “Offering”). In the Offering, we sold an aggregate of 847,371 shares at $95.00 per share. We received net proceeds of $75.2 million in the Offering, a portion of which was used during the third quarter of fiscal year 2024 to repay in full our revolving credit facility. See “Liquidity and Capital Resources” below for more information. 

Executive Summary

During our third quarter of fiscal year 2024, we had consolidated revenue of $65.2 million. This represented an increase of $7.8 million or 13.5% versus the third quarter of fiscal year 2023. This increase was primarily due to recently completed acquisitions, strong demand in our Service segment’s highly-regulated end markets and increased rental sales, which includes incremental revenue from an acquisition completed in fiscal year 2024.  See Note 5 – “Business Acquisitions” to our unaudited consolidated financial statements in this report for more information about the impact of our acquisitions.

Our third quarter of fiscal year 2024 gross profit was $20.9 million. This was an increase of $4.5 million or 27.7% versus the third quarter of fiscal year 2023. In addition, consolidated gross margin was 32.1%, an increase of 350 basis points versus the third quarter of fiscal year 2023. This increase was largely the result of operating leverage on our fixed costs, increased technician productivity and accretive gross margins from our rental business.

Total operating expenses were $16.6 million in the third quarter of fiscal year 2024, an increase of $3.4 million or 25.7% when compared to the prior year third quarter. Included in operating expenses during the third quarter of fiscal year 2024 were incremental operating expenses from the acquisitions of Axiom, SteriQual, TIC-MS, investments in technology and higher incentive-based employee costs due to higher sales. As a percentage of total revenue, operating expenses were 25.5% in the third quarter of fiscal year 2024, up 240 basis points from 23.1% in the third quarter of fiscal year 2023. Operating income was $4.3 million, an increase of $1.1 million, or 35.8% and operating margin increased from 5.5% to 6.6% in the third quarter of fiscal year 2024.

Net income was $3.3 million in the third quarter of fiscal year 2024 versus $1.6 million in the third quarter of fiscal year 2023. The increase was primarily due to higher operating income and lower interest expense associated with the repayment of our revolving credit facility, partially offset by higher provision for income taxes.

21

The following table presents, for the third quarter and for the first nine months of fiscal year 2024 and fiscal year 2023, the components of our Consolidated Statements of Income:

	(Unaudited)						(Unaudited)
	Third Quarter Ended						Nine Months Ended
	December 23,			December 24,			December 23,			December 24,
	2023			2022			2023			2022
As a Percentage of Total Revenue:
Service Revenue		63.7	%		62.7	%		65.1	%		62.4	%
Distribution Sales		36.3	%		37.3	%		34.9	%		37.6	%
Total Revenue		100.0	%		100.0	%		100.0	%		100.0	%
Gross Profit Percentage:
Service Gross Profit		32.5	%		30.0	%		33.0	%		31.5	%
Distribution Gross Profit		31.5	%		26.2	%		29.2	%		25.4	%
Total Gross Profit		32.1	%		28.6	%		31.7	%		29.2	%
Selling, Marketing and Warehouse Expenses		11.5	%		11.5	%		11.1	%		10.9	%
General and Administrative Expenses		14.0	%		11.6	%		15.0	%		12.2	%
Total Operating Expenses		25.5	%		23.1	%		26.1	%		23.0	%
Operating Income		6.6	%		5.5	%		5.6	%		6.2	%
Interest and Other Expense, net		0.0	%		1.8	%		0.9	%		1.0	%
Income Before Income Taxes		6.6	%		3.7	%		4.7	%		5.1	%
Provision for Income Taxes		1.5	%		0.9	%		1.1	%		1.0	%
Net Income		5.1	%		2.8	%		3.6	%		4.2	%

Third Quarter Ended December 23, 2023 COMPARED TO Third Quarter Ended December 24, 2022 (dollars in thousands):

Revenue:

	Third Quarter Ended				Change
	December 23,		December 24,
	2023		2022		$		%
Revenue:
Service	$	41,509	$	35,977	$	5,532		15.4	%
Distribution		23,657		21,425		2,232		10.4	%
Total	$	65,166	$	57,402	$	7,764		13.5	%

Total revenue was $65.2 million, an increase of $7.8 million, or 13.5%, in our fiscal year 2024 third quarter compared to the prior fiscal year third quarter.

Service revenue, which accounted for 63.7% and 62.7% of our total revenue in the third quarter of fiscal years 2024 and 2023, respectively, increased $5.5 million or 15.4% from the third quarter of fiscal year 2023 to the third quarter of fiscal year 2024. This year-over-year increase included $2.2 million in revenue from the acquisitions of TIC-MS, SteriQual and Axiom, and also included organic revenue growth of 9.1% driven by strong end-market demand and continued market share gains.

22

Our fiscal years 2024 and 2023 Service revenue growth, in relation to prior fiscal year quarter comparisons, was as follows:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Service Revenue Growth		15.4	%		17.5	%		17.6	%		14.7	%		19.0	%		19.4	%		22.9	%

The growth in Service segment revenue during the third quarter of fiscal year 2024 versus the third quarter of fiscal year 2023 reflected both organic growth and increased revenue from the acquisitions of TIC-MS, SteriQual and Axiom.

Within any fiscal year, while we add new customers, we also have customers from the prior fiscal year whose service orders may not repeat for any number of factors. Among those factors are variations in the timing of periodic calibrations and other services, customer capital expenditures and customer outsourcing decisions. Because the timing of Service segment orders can vary on a quarter-to-quarter basis, we believe trailing twelve-month information provides a better indication of the progress of this segment.

The following table presents the trailing twelve-month Service segment revenue for the first, second and third quarter of fiscal year 2024 and each quarter in fiscal year 2023 as well as the trailing twelve-month revenue growth as a comparison to that of the prior fiscal year period:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Trailing Twelve-Month:
Service Revenue	$	162,556		$	157,024		$	150,860		$	144,883		$	139,787		$	134,047		$	128,324
Service Revenue Growth		16.3	%		17.1	%		17.6	%		18.8	%		20.2	%		20.9	%		21.2	%

Our strategy has been to focus our investments in the core electrical, temperature, pressure, physical/dimensional and radio frequency/microwave calibration disciplines. We expect to subcontract approximately 13% to 15% of our Service revenue to third-party vendors for calibration beyond our chosen scope of capabilities. We continually evaluate our outsourcing needs and make capital investments, as deemed necessary, to add more in-house capabilities and reduce the need for third-party vendors. Capability expansion through business acquisitions is another way that we seek to reduce the need for outsourcing. The following table presents the source of our Service revenue and the percentage of Service revenue derived from each source for the first, second and third quarter of fiscal year 2024 and for each quarter during fiscal year 2023:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Percent of Service Revenue:
In-House		86.2	%		85.8	%		87.3	%		86.9	%		86.2	%		86.2	%		85.4	%
Outsourced		12.6	%		13.0	%		11.6	%		11.9	%		12.6	%		12.6	%		13.2	%
Freight Billed to Customers		1.2	%		1.2	%		1.1	%		1.2	%		1.2	%		1.2	%		1.4	%
		100.0	%		100.0	%		100.0	%		100.0	%		100.0	%		100.0	%		100.0	%

23

Our Distribution sales accounted for 36.3% of our total revenue in the third quarter of fiscal year 2024 and 37.3% of our total revenue in the third quarter of fiscal year 2023. During the third quarter of fiscal year 2024, Distribution segment sales were $23.7 million which was an increase of 10.4% or $2.2 million . This increase was due to $2.9 million of incremental revenue from the acquisition of Axiom offset by slower demand for our non-rental products.

The following table presents the quarterly historical trend of Distribution sales in fiscal years 2024 and 2023 compared to the prior year fiscal quarter:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Distribution Sales Growth (Decline)		10.4	%		0.9	%		(0.2	)%		5.1	%		3.7	%		1.6	%		2.7	%

The Distribution segment sales increase for the third quarter of fiscal year 2024 versus the third quarter of fiscal year 2023 was due to sales from the acquisition of Axiom.

Distribution sales orders include orders for instruments that we routinely stock in our inventory, customized products, and other products ordered less frequently, which we do not stock. Product backorders are the total dollar value of orders received for which revenue has not yet been recognized. Pending product shipments are primarily backorders, but also include products that are requested to be calibrated in our service centers prior to shipment, orders required by the customer to be shipped complete or at a future date, and other orders awaiting final credit or management review prior to shipment. Management uses pending product shipments and backorders as measures of our future business performance and financial performance within the distribution segment.

The following table presents our total pending product shipments and the percentage of total pending product shipments that were backorders at the end of the first, second and  third quarter of fiscal year 2024 and each quarter of fiscal year 2023:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Total Pending Product Shipments	$	4,652		$	6,332		$	7,109		$	8,101		$	9,543		$	9,116		$	9,034
% of Pending Product
Shipments that were Backorders		82.0	%		87.4	%		85.0	%		84.8	%		78.4	%		80.8	%		78.1	%

Our total pending product shipments at the end of the third quarter of fiscal year 2024 were $4.7 million, a decrease of $4.9 million versus the end of the third quarter of fiscal year 2023 and a decrease of $3.5 million since March 25, 2023. The decrease in pending product shipments and backorders was a result of improved fulfillment of existing orders.

Gross Profit:

	Third Quarter Ended				Change
	December 23,		December 24,
	2023		2022		$		%
Gross Profit:
Service	$	13,494	$	10,793	$	2,701		25.0	%
Distribution		7,442		5,607		1,835		32.7	%
Total	$	20,936	$	16,400	$	4,536		27.7	%

Total gross profit for the third quarter of fiscal year 2024 was $20.9 million, an increase of $4.5 million or 27.7% versus the third quarter of fiscal year 2023. Total gross margin was 32.1% in the third quarter of fiscal year 2024, up from 28.6% in the third quarter of fiscal year 2023, a 350 basis point increase.

Service gross profit in the third quarter of fiscal year 2024 increased $2.7 million, or 25.0%, from the third quarter of fiscal year 2023. Service gross margin was 32.5% in the third quarter of fiscal year 2024, a 250 basis point increase versus the third quarter of fiscal year 2023. This increase in gross margin was the result of increased revenue, which allows us to leverage our fixed-costs, and continued increases in technician productivity.

24

The following table presents the quarterly historical trend of our Service gross margin as a percent of Service revenue:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Service Gross Margin		32.5	%		34.0	%		32.5	%		34.0	%		30.0	%		32.6	%		32.0	%

Our Distribution gross margin includes net sales less the direct cost of inventory sold and the direct costs of equipment rental revenues, primarily depreciation expense for the fixed assets in our rental equipment pool, as well as the impact of rebates and cooperative advertising income we receive from vendors, freight billed to customers, freight expenses and direct shipping costs. In general, our Distribution gross margin can vary based upon the mix of products sold, price discounting, and the timing of periodic vendor rebates offered and cooperative advertising programs from suppliers.

The following table reflects the quarterly historical trend of our Distribution gross margin as a percent of Distribution sales:

	FY 2024									FY 2023
	Q3			Q2			Q1			Q4			Q3			Q2			Q1
Distribution Gross Margin		31.5	%		28.3	%		27.7	%		25.2	%		26.2	%		24.9	%		25.0	%

Distribution segment gross margin was 31.5% in the third quarter of fiscal year 2024 versus 26.2% in the third quarter of fiscal year 2023, a 530 basis point increase. The increase in segment gross margin was primarily due to increased margins from rental revenue, which now includes Axiom and a favorable mix of higher margin products sold.

Operating Expenses:

	Third Quarter Ended				Change
	December 23,		December 24,
	2023		2022		$		%
Operating Expenses:
Selling, Marketing and Warehouse	$	7,519	$	6,595	$	924		14.0	%
General and Administrative		9,123		6,642		2,481		37.4	%
Total	$	16,642	$	13,237	$	3,405		25.7	%

Total operating expenses were $16.6 million in the third quarter of fiscal year 2024 versus $13.2 million during the third quarter of fiscal year 2023. The year-over-year increase in selling, marketing and warehouse expenses is due to increased expenses related to recent acquisitions and higher incentive-based employee costs due to higher sales. The increase in general and administrative expenses includes incremental expenses related to acquired companies, increased payroll costs for new employees and continued investments in technology.

As a percentage of total revenue, operating expenses were 25.5% in the third quarter of fiscal year 2024 and 23.1% in the third quarter of fiscal year 2023, an increase of 240 basis points.

Income Taxes:

	Third Quarter Ended				Change
	December 23,		December 24,
	2023		2022		$		%
Provision for Income Taxes	$	923	$	523	$	400		76.5	%

Our effective tax rate for the third quarter of fiscal years 2024 and 2023 was 21.6% and 24.6%, respectively. The increase in the tax provision is due to higher operating income and lower interest expense associated with the repayment of our revolving credit facility. The decrease in effective tax rate is due to the mix of net income by country.  Our quarterly provision for income taxes is affected by discrete items that may occur in any given period but are not consistent from year to year. The discrete benefits related to share-based compensation activity in the third quarter of fiscal years 2024 and 2023 was less than $0.1 million.

25

Net Income:

	Third Quarter Ended				Change
	December 23,		December 24,
	2023		2022		$		%
Net Income	$	3,348	$	1,601	$	1,747		109.1	%

Net income for the third quarter of fiscal year 2024 increased from the third quarter of fiscal year 2023 primarily due to higher operating income and lower interest expense associated with the repayment of our revolving credit facility, partially offset by a higher provision for income taxes.

Adjusted EBITDA:

Total Adjusted EBITDA, a non-GAAP measure, for the third quarter of fiscal year 2024 was $9.1 million, an increase of $2.5 million or 38.5% versus the third quarter of fiscal year 2023. See “Non-GAAP Financial Measures” below for a description of the non-GAAP measures we use and a reconciliation to the most directly comparable GAAP measures. As a percentage of revenue, Adjusted EBITDA increased to 14.0% for the third quarter of fiscal year 2024 from 11.5% for the third quarter of fiscal year 2023. The increase in Adjusted EBITDA during the third quarter of fiscal year 2024 was primarily driven by increases in operating income, depreciation and amortization expense and non-cash stock compensation.

nine months ended December 23, 2023 COMPARED TO nine months ended December 24, 2022 (dollars in thousands):

Revenue:

	Nine Months Ended				Change
(dollars in thousands)	December 23,		December 24,
	2023		2022		$		%
Revenue:
Service	$	122,793	$	105,120	$	17,673		16.8	%
Distribution		65,775		63,382		2,393		3.8	%
Total	$	188,568	$	168,502	$	20,066		11.9	%

Service revenue, which accounted for 65.1% and 62.4% of our total revenue in the first nine months of fiscal years 2024 and 2023, respectively, increased $17.7 million, or 16.8%, from the first nine months of fiscal year 2023 to the first nine months of fiscal year 2024. This year-over-year increase included $7.1 million of incremental revenue from the acquisitions of TIC-MS, SteriQual and Axiom, and also included organic revenue growth of 10.0% driven by strong end-market demand and continued market share gains.

Distribution revenue, which accounted for 34.9% and 37.6% of our total revenue in the first nine months of fiscal years 2024 and 2023, respectively, increased $2.4 million, or 3.8%, from the first nine months of fiscal year 2023 to the first nine months of fiscal year 2024. This year-over-year increase is primarily due to $4.2 million of incremental revenue from the acquisition of Axiom offset by slower demand for our non-rental products.

26

Gross Profit:

	Nine Months Ended				Change
(dollars in thousands)	December 23,		December 24,
	2023		2022		$		%
Gross Profit:
Service	$	40,549	$	33,115	$	7,434		22.4	%
Distribution		19,222		16,090		3,132		19.5	%
Total	$	59,771	$	49,205	$	10,566		21.5	%

Total gross profit for the first nine months of fiscal year 2024 was $59.8 million, an increase of $10.6 million or 21.5% versus the first nine months of fiscal year 2023. Total gross margin was 31.7% in the first nine months of fiscal year 2024, up from 29.2% in the first nine months of fiscal year 2023, a 250 basis point increase. This increase in gross margin was primarily due to increased revenue in our Service segment, which allows us to leverage our fixed costs, continued technician productivity improvements, and a favorable sales mix driven by increases in rental sales in the Distribution segment.

Operating Expenses:

	Nine Months Ended				Change
(dollars in thousands)	December 23,		December 24,
	2023		2022		$		%
Operating Expenses:
Selling, Marketing and Warehouse	$	20,844	$	18,315	$	2,529		13.8	%
General and Administrative		28,350		20,497		7,853		38.3	%
Total	$	49,194	$	38,812	$	10,382		26.7	%

Total operating expenses were $49.2 million in the first nine months of fiscal year 2024 versus $38.8 million during the first nine months of fiscal year 2023, an increase of $10.4 million or 26.7%. The year-over-year increase in selling, marketing and warehouse expenses is due to increased expenses related to recent acquisitions and higher incentive-based employee costs due to higher sales. The increase in general and administrative expenses includes the non-cash charge related to the NEXA earn-out, incremental expenses related to acquired companies, increased payroll costs for new employees and continued investments in technology.

As a percentage of total revenue, operating expenses were 26.1% in the first nine months of fiscal year 2024 and 23.0% in the first nine months of fiscal year 2023, an increase of 310 basis points.

Income Taxes:

	Nine Months Ended				Change
(dollars in thousands)	December 23,		December 24,
	2023		2022		$		%
Provision for Income Taxes	$	2,078	$	1,631	$	447		27.4	%

Our effective tax rate for the first nine months of fiscal years 2024 and 2023 was 23.5% and 18.8%, respectively. The increase in the effective rate and tax provision is due to the discrete tax treatment of the non-cash charge related to the NEXA earn-out. Our provision for income taxes is affected by discrete items that may occur in any given period but are not consistent from year to year. The discrete benefits related to share-based compensation activity in the first nine months of fiscal years 2024 and 2023 was $0.7 million and $0.5 million, respectively.

27

Net Income:

	Nine Months Ended				Change
	December 23,		December 24,
	2023		2022		$			%
Net Income	$	6,757	$	7,030	$	(273	)		(3.9	)%

Net income for the first nine months of fiscal year 2024 was $6.8 million, a decrease of $0.3 million versus the first nine months of fiscal year 2023. The year over year decrease in net income was primarily due to flat operating income and a higher provision for income taxes.

Adjusted EBITDA:

Total Adjusted EBITDA, a non-GAAP measure, for the first nine months of fiscal year 2024 was $26.9 million, an increase of $5.5 million or 25.7% versus the first nine months of fiscal year 2023. See “Non-GAAP Financial Measures” below for a description of the non-GAAP measures we use and a reconciliation to the most directly comparable GAAP measures. As a percentage of revenue, Adjusted EBITDA increased to 14.3% for the first nine months of fiscal year 2024 from 12.7% for the first nine months of fiscal year 2023. The increase in Adjusted EBITDA during the first nine months of fiscal year 2024 was primarily driven by the NEXA earn-out adjustment and increases in depreciation and amortization expense and non-cash stock compensation.

Non-GAAP Financial Measures

Adjusted EBITDA

In addition to reporting net income, a GAAP measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, acquisition related transaction expenses, non-cash loss on sale of building, and restructuring expense), which is a non-GAAP measure. Our management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and others to evaluate and compare the performance of our core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense and other items, which is not always commensurate with the reporting period in which it is included. As such, our management uses Adjusted EBITDA as a measure of performance when evaluating our business segments and as a basis for planning and forecasting. Adjusted EBITDA is also commonly used by rating agencies, lenders and other parties to evaluate our credit worthiness.

Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute or alternative for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

	Third Quarter Ended						Nine Months Ended
(dollars in thousands)	December 23,			December 24,			December 23,			December 24,
	2023			2022			2023			2022
Net Income	$	3,348		$	1,601		$	6,757		$	7,030
+ Interest (Income) Expense		(266	)		726			1,438			1,636
+ Other Expense		289			313			304			96
+ Tax Provision		923			523			2,078			1,631
Operating Income		4,294			3,163			10,577			10,393
+ Depreciation & Amortization		3,783			2,824			9,842			8,243
+ Transaction Expense		78			96			591			126
+ Acquisition Earn-Out Adjustment		87			-			2,887			-
+ Other (Expense)		(289	)		(313	)		(304	)		(96	)
+ Noncash Stock Compensation		1,167			815			3,338			2,757
Adjusted EBITDA	$	9,120		$	6,585		$	26,931		$	21,423

28

Adjusted Diluted Earnings Per Share

In addition to reporting Diluted Earnings Per Share, a GAAP measure, we present Adjusted Diluted Earnings Per Share (net income plus acquisition related amortization expense, acquisition related transaction expenses, acquisition related stock-based compensation, acquisition amortization of backlog and restructuring expense; divided by the average diluted shares outstanding during the period), which is a non-GAAP measure. Our management believes Adjusted Diluted Earnings Per Share is an important measure of our operating performance because it provides a basis for comparison of our business operations between current, past and future periods by excluding items that we do not believe are indicative of our core operating performance.

Adjusted Diluted Earnings Per Share is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute or alternative for the GAAP measure of Diluted Earnings Per Share and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted Diluted Earnings Per Share, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

	Third Quarter Ended						Nine Months Ended
	December 23,			December 24,			December 23,			December 24,
	2023			2022			2023			2022
Net Income	$	3,348		$	1,601		$	6,757		$	7,030
+ Amortization of Intangible Assets		1,674			1,180			4,183			3,411
+ Acquisition Amortization of Backlog		24			-			43			-
+ Acquisition Deal Costs		343			254			1,312			792
+ Income Tax Effect @ 25%		(532	)		(359	)		(1,406	)		(1,051	)
+ Acquisition Earn-Out Adjustment		87			-			2,887			-
Adjusted Net Income		4,944			2,676			13,776			10,182
Average Diluted Shares Outstanding		8,752			7,666			8,187			7,644
Diluted Earnings Per Share – GAAP	$	0.38		$	0.21		$	0.83		$	0.92
Adjusted Diluted Earnings Per Share	$	0.56		$	0.35		$	1.68		$	1.33

LIQUIDITY AND CAPITAL RESOURCES

We expect that foreseeable liquidity and capital resource requirements will be met through cash and cash equivalents, anticipated cash flows from operations and borrowings from our revolving credit facility. We believe that these sources of financing will be adequate to meet our future requirements.

Under our Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), we have access to a revolving credit commitment (the “Revolving Credit Commitment”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million. Our 2018 term loan, with an original principal amount of $15.0 million (the “2018 Term Loan”), is also provided for under the Credit Agreement.

The Credit Agreement allows us to use up to $50.0 million under the Revolving Credit Commitment for acquisitions in any single fiscal year. The Credit Agreement restricts our ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the Revolving Credit Commitment. Under the Credit Agreement, we may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

29

Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at our election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin. Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon our calculated leverage ratio. Our interest rate for the revolving credit facility for the first nine months of fiscal year 2024 ranged from 6.4% to 7.1%. Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

The Credit Agreement has certain covenants with which we must comply, including a fixed charge ratio covenant, which prohibits our fixed charge coverage ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits our leverage ratio from exceeding 3.00 to 1.00. We were in compliance with all loan covenants and requirements during the first nine months of fiscal year 2024. Our leverage ratio, as defined in the Credit Agreement, was 0.12 at December 23, 2023, compared with 1.60 at March 25, 2023.

As of December 23, 2023, $80.0 million was available for borrowing under the revolving credit facility.  As of December, 23, 2023, there were no amounts outstanding under the revolving credit facility. After the closing of the Offering, we used approximately $50.0 million of the net proceeds to repay in full the amounts outstanding under the revolving credit facility.  During the first nine months of fiscal year 2024 and 2023, we used $12.9 million and $4.0 million, respectively, drawn from the revolving credit facility for business acquisitions. 

As of December 23, 2023, $4.7 million was outstanding on the 2018 Term Loan, of which $2.3 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total repayments (principal plus interest) of $0.2 million per month through December 2025.

Cash Flows: The following table is a summary of our Consolidated Statements of Cash Flows (dollars in thousands):

	Nine Months Ended
	December 23,			December 24,
	2023			2022
Cash Provided by (Used in):
Operating Activities	$	26,889		$	13,975
Investing Activities	$	(22,031	)	$	(15,445	)
Financing Activities	$	29,076		$	782

Operating Activities: Net cash provided by operations was $26.9 million during the first nine months of fiscal year 2024 compared to $14.0 million of net cash provided by operating activities during the first nine months of fiscal year 2023. The year-over-year increase in cash provided by operations was primarily the result of changes in net working capital (defined as current assets less current liabilities). The significant working capital fluctuations were as follows:

● Receivables: Accounts receivable decreased $1.4 million during the first nine months of fiscal year 2024 inclusive of $2.6 million of accounts receivable acquired during the period. During the first nine months of fiscal year 2023, accounts receivable increased $2.0 million inclusive of $0.7 million of accounts receivable acquired during the period. The year-over-year variation reflects changes in the timing of collections. The following table illustrates our “days sales outstanding” as of December 23, 2023 and December 24, 2022 (dollars in thousands):

	December 23,		December 24,
	2023		2022
Net Sales, for the last two fiscal months	$	45,501	$	40,088
Accounts Receivable, net	$	43,307	$	37,702
Days Sales Outstanding		57		59

30

● Inventory: Our inventory strategy includes making appropriate large quantity, high dollar purchases with key manufacturers for various reasons, including maximizing on-hand availability of key products, expanding the number of SKUs stocked in anticipation of customer demand, reducing backorders for products with long lead times and optimizing vendor purchase and sales volume discounts. As a result, inventory levels may vary from quarter-to-quarter based on the timing of these large orders in relation to our quarter end. Our inventory balance decreased $0.8 million during the first nine months of fiscal year 2024 inclusive of $1.8 million of inventory acquired during the period.  Our inventory balance increased by $4.2 million during the first nine months of fiscal year 2023 due to strategic inventory purchases during the first nine months of the fiscal year.

● Accounts Payable: Changes in accounts payable may or may not correlate with changes in inventory balances at any given quarter end due to the timing of vendor payments for inventory, as well as the timing of payments for outsourced Service vendors and capital expenditures.  Accounts payable decreased $4.5 million during the first nine months of fiscal year 2024.  Accounts payable decreased $0.3 million during the first nine months of fiscal year 2023. The variances are largely due to the timing of inventory and capital expenditures and other payments in the respective periods.

● Accrued Compensation and Other Current Liabilities: Accrued compensation and other current liabilities include, among other things, amounts paid to employees for non-equity performance-based compensation. At the end of any particular period, the amounts accrued for such compensation may vary due to many factors including changes in expected performance levels, the performance measurement period, and timing of payments to employees.  During the first nine months of fiscal year 2024, accrued compensation and other current liabilities increased by $5.5 million, inclusive of $4.0 million from assumed liabilities, contingent consideration and purchase price holdbacks from acquisition transactions. During the first nine months of fiscal year 2023, accrued compensation and other current liabilities decreased by $2.4 million. The change from the first nine months of fiscal year 2023 was largely due to the inclusion of the acquisition related transactions, partially offset by the annual payment of incentive based compensation accruals.

● Income Taxes Payable: In any given period, net working capital may be affected by the timing and amount of income tax payments. During the first nine months of fiscal years 2024 and 2023, income taxes payable remained flat.

Investing Activities: During the first nine months of fiscal years 2024 and 2023, we invested $9.1 million and $7.1 million, respectively, in capital expenditures that was used primarily for customer-driven expansion of Service segment capabilities and our rental business.

During the first nine months of fiscal years 2024 and 2023, we used $12.9 million and $8.3 million, respectively, for business acquisitions.

During the first nine months of fiscal year 2024, we paid $0.8 million of other holdback amounts relating to business acquisitions.  During the first nine months of fiscal year 2023, no contingent consideration or other holdback amounts were paid related to business acquisitions.

Financing Activities: During the first nine months of fiscal year 2024, $75.7 million in cash was generated from the issuance of common stock, net of direct costs of the Offering. In addition, we used $42.7 million to repay our revolving line of credit, $1.7 million for scheduled repayments of our term loan and $2.2 million for the “net” awarding of certain share awards to cover employee tax-withholding obligations for share award and stock option activity in fiscal year 2024, which are shown as a repurchase of shares of our common stock.

During the first nine months of fiscal year 2023, $2.3 million was borrowed from our revolving line of credit and $0.5 million in cash was generated from the issuance of common stock. In addition, we used $1.6 million for scheduled repayments of our term loan and $0.4 million for the “net” awarding of certain share awards to cover employee tax-withholding obligations for share award and stock option activity in the quarter, which are shown as a repurchase of shares of our common stock.

31

OUTLOOK

We are proud of our dedicated team, which has consistently delivered exceptional results through various economic cycles as can be seen over the past decade and a half of profitable growth. During this fiscal year, we expect organic Service revenue growth in the high-single digit to low double-digit range and gross margin expansion. Automation of our calibration processes and overall process improvement will be key enablers to future margin expansion in the Service segment. We believe the Service segment has substantial runway ahead for growth, both organically and through acquisition. Our robust and diverse acquisition pipeline enables strategic, accretive acquisitions that drive synergistic growth opportunities and will be a key component of our future strategy. We believe our unique value proposition drives a sustainable competitive advantage in the highly regulated markets that we serve, particularly the Life Science, Aerospace, and Defense markets, along with a growing Rentals business. We have a long history of generating sustainable value for our shareholders and providing a dynamic, rewarding workplace for our team.

We expect our income tax rate to range between 24% and 26% for full fiscal year 2024. This estimate includes Federal, various state, Canadian and Irish income taxes and reflects the discrete tax accounting associated with share-based payment awards. 

32

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

INTEREST RATES

Our exposure to changes in interest rates results from our borrowing activities. In the event interest rates were to move by 1%, our yearly interest expense would increase or decrease by approximately $0.5 million assuming our average borrowing levels during the first nine months of fiscal year 2024 remained constant under the revolving credit facility. As of December 23, 2023, $80.0 million was available for borrowing under the revolving credit facility.  As of December 23, 2023, there were no amounts outstanding under the revolving credit facility. As described above under “Liquidity and Capital Resources,” we also have a $15.0 million (original principal) term loan. The 2018 Term Loan is considered a fixed interest rate loan. As of December 23, 2023, $4.7 million was outstanding under the 2018 Term Loan and was included in long-term debt and current portion of long-term debt on the Consolidated Balance Sheets. The 2018 Term Loan requires total (principal and interest) repayments of $0.2 million per month.

Effective July 1, 2023, at our option, we may borrow from our revolving credit facility at the variable one-month Daily Simple SOFR or at a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin. Our interest rate margin is determined on a quarterly basis based upon our calculated leverage ratio. Our interest rate during the first nine months of fiscal year 2024 for our revolving credit facility ranged from 6.4% to 7.1%. Interest on outstanding borrowings of the 2018 Term Loan accrued at a fixed rate of 3.90% over the term of the loan. On December 23, 2023, we had no hedging arrangements in place for our revolving credit facility to limit our exposure to movements in interest rates.  

FOREIGN CURRENCY

Approximately 90% of our total revenues for each of the first nine months of fiscal year 2024 and 2023 were denominated in U.S. dollars, with the remainder denominated in Canadian dollars and Euros. A 10% change in the value of the Canadian dollar to the U.S. dollar and the Euro to the U.S. dollar would impact our revenue by approximately 1%. We monitor the relationship between the U.S. dollar and the Canadian dollar and the U.S. dollar and the Euro on a monthly basis and adjust sales prices for products and services sold in Canadian dollars or Euros as we believe to be appropriate.

We continually utilize short-term foreign exchange forward contracts to reduce the risk that future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. We do not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a loss of $0.1 million and a gain of $0.3 million during the first nine months of the fiscal years 2024 and 2023, respectively, was recognized as a component of Interest and Other Expense, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On December 23, 2023, we had a foreign exchange contract, which matured in January 2024, outstanding in the notional amount of $2.0 million. The foreign exchange contract was renewed in January 2024 and continues to be in place. We do not use hedging arrangements for speculative purposes.

ITEM 4. CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures. Our principal executive officer and our principal financial officer evaluated our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our principal executive officer and principal financial officer to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of such date.

Changes in Internal Control over Financial Reporting. There has been no change in our internal control over financial reporting that occurred during the last fiscal quarter covered by this quarterly report (our third quarter of fiscal year 2024) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

33

PART II. OTHER INFORMATION

34

ITEM 6. EXHIBITS

INDEX TO EXHIBITS

Exhibit No.	Description
(31)	Rule 13a-14(a)/15d-14(a) Certifications
	31.1*	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	31.2*	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
(32)	Section 1350 Certifications
	32.1**	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

35

(101)	Interactive Data File
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
(104)		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Exhibit filed with this report.

** Exhibit furnished with this report.

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TRANSCAT, INC.
Date: January 31, 2024	/s/ Lee D. Rudow
	Lee D. Rudow
	President and Chief Executive Officer (Principal Executive Officer)
Date: January 31, 2024	/s/ Thomas L. Barbato
	Thomas L. Barbato
	Senior Vice President of Finance and Chief Financial Officer (Principal Financial Officer)

37

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lee D. Rudow, President and Chief Executive Officer of Transcat, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 31, 2024	/s/ Lee D. Rudow
	Lee D. Rudow
	President and Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas L. Barbato, Senior Vice President of Finance and Chief Financial Officer of Transcat, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 31, 2024	/s/ Thomas L. Barbato
	Thomas L. Barbato
	Senior Vice President of Finance and Chief Financial Officer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Transcat, Inc., Lee D. Rudow, the Chief Executive Officer of Transcat, Inc. and Thomas L. Barbato, the Chief Financial Officer of Transcat, Inc. certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their knowledge, that:

1. This quarterly report on Form 10-Q for the third quarter ended December 23, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in this quarterly report on Form 10-Q for the third quarter ended December 23, 2023 fairly presents, in all material respects, the financial condition and results of operations of Transcat, Inc.

Date: January 31, 2024	/s/ Lee D. Rudow
	Lee D. Rudow
	President and Chief Executive Officer (Principal Executive Officer)

Date: January 31, 2024	/s/ Thomas L. Barbato
	Thomas L. Barbato
	Senior Vice President of Finance and Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Transcat, Inc. and will be retained by Transcat, Inc. and furnished to the SEC or its staff upon request.

XML

Document And Entity Information - shares	9 Months Ended
	Dec. 23, 2023	Jan. 26, 2024
Document Information [Line Items]
Entity Central Index Key	0000099302
Entity Registrant Name	TRANSCAT INC
Amendment Flag	false
Current Fiscal Year End Date	--03-25
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 23, 2023
Document Transition Report	false
Entity File Number	000-03905
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	16-0874418
Entity Address, Address Line One	35 Vantage Point Drive
Entity Address, City or Town	Rochester
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14624
City Area Code	585
Local Phone Number	352-7777
Title of 12(b) Security	Common Stock, $0.50 par value
Trading Symbol	TRNS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,829,127

XML

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Dec. 23, 2023	Dec. 24, 2022	Dec. 23, 2023	Dec. 24, 2022
Revenue	[1]	$ 65,166	$ 57,402	$ 188,568	$ 168,502
Cost of Service Revenue		44,230	41,002	128,797	119,297
Gross Profit		20,936	16,400	59,771	49,205
Selling, Marketing and Warehouse Expenses		7,519	6,595	20,844	18,315
General and Administrative Expenses		9,123	6,642	28,350	20,497
Total Operating Expenses		16,642	13,237	49,194	38,812
Operating Income		4,294	3,163	10,577	10,393
Interest Expense		81	731	1,785	1,651
Interest Income		(347)	(5)	(347)	(15)
Other Income/Expense		289	313	304	96
Total Interest and Other		23	1,039	1,742	1,732
Income Before Income Taxes		4,271	2,124	8,835	8,661
Provision for Income Taxes		923	523	2,078	1,631
Net Income		$ 3,348	$ 1,601	$ 6,757	$ 7,030
Basic Earnings Per Share (in dollars per share)		$ 0.39	$ 0.21	$ 0.84	$ 0.93
Average Shares Outstanding (in shares)		8,615	7,559	8,060	7,547
Diluted Earnings Per Share (in dollars per share)		$ 0.38	$ 0.21	$ 0.83	$ 0.92
Average Shares Outstanding (in shares)		8,752	7,666	8,187	7,644
Service [Member]
Revenue		$ 41,509	$ 35,977	$ 122,793	$ 105,120
Cost of Service Revenue		28,015	25,184	82,244	72,005
Distribution Service [Member]
Revenue		23,657	21,425	65,775	63,382
Cost of Service Revenue		$ 16,215	$ 15,818	$ 46,553	$ 47,292

[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

XML

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 23, 2023	Dec. 24, 2022	Dec. 23, 2023	Dec. 24, 2022
Net Income	$ 3,348	$ 1,601	$ 6,757	$ 7,030
Other Comprehensive Income (Loss):
Currency Translation Adjustment	364	393	488	(878)
Other, net of tax effects of $3 and $2 for the third quarter ended December 23, 2023 and December 24, 2022, respectively; and $7 and $(4) for the nine months ended December 23, 2023 and December 24, 2022, respectively	9	8	21	(12)
Total Other Comprehensive Income (Loss)	373	401	509	(890)
Comprehensive Income	$ 3,721	$ 2,002	$ 7,266	$ 6,140

XML

Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 23, 2023	Dec. 24, 2022	Dec. 23, 2023	Dec. 24, 2022
Other, tax effect	$ 3	$ 2	$ 7	$ (4)

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 23, 2023	Mar. 25, 2023
Current Assets:
Cash and cash equivalents	$ 35,205	$ 1,531
Accounts Receivable, less allowance for credit losses of $579 and $457 as of December 23, 2023 and March 25, 2023, respectively	43,307	44,698
Other Receivables	819	506
Inventory, net	16,178	16,929
Prepaid Expenses and Other Current Assets	3,295	3,935
Total Current Assets	98,804	67,599
Property and Equipment, net	37,222	29,064
Goodwill	105,700	69,360
Intangible Assets, net	21,459	13,799
Right To Use Assets, net	16,834	14,876
Other Assets	1,055	1,051
Total Assets	281,074	195,749
Current Liabilities:
Accounts Payable	11,355	15,869
Accrued Compensation and Other Current Liabilities	15,683	10,201
Current Portion of Long-Term Debt	2,316	2,248
Total Current Liabilities	29,354	28,318
Long-Term Debt	2,411	46,869
Deferred Tax Liabilities, net	10,855	6,538
Lease Liabilities	14,457	12,960
Other Liabilities	5,527	1,434
Total Liabilities	62,604	96,119
Shareholders' Equity:
Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 8,828,515 and 7,562,604 shares issued and outstanding as of December 23, 2023 and March 25, 2023, respectively	4,414	3,781
Capital in Excess of Par Value	140,382	27,886
Accumulated Other Comprehensive Loss	(691)	(1,200)
Retained Earnings	74,365	69,163
Total Shareholders' Equity	218,470	99,630
Total Liabilities and Shareholders' Equity	$ 281,074	$ 195,749

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 23, 2023	Mar. 25, 2023
Accounts Receivable, allowance for doubtful accounts	$ 579	$ 457
Common stock, par value (in dollars per share)	$ 0.5	$ 0.5
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	8,828,515	7,562,604
Common stock, shares outstanding (in shares)	8,828,515	7,562,604

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 23, 2023	Dec. 24, 2022
Cash Flows from Operating Activities:
Net Income	$ 6,757	$ 7,030
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Net Loss on Disposal of Property and Equipment	24	62
Deferred Income Taxes	42	(52)
Depreciation and Amortization	9,841	8,243
Provision for Accounts Receivable and Inventory Reserves	379	174
Stock-Based Compensation Expense	3,338	2,757
Changes in Assets and Liabilities, net of acquisitions:
Accounts Receivable and Other Receivables	3,819	1,850
Inventory	3,208	(3,589)
Prepaid Expenses and Other Current Assets	728	1,074
Accounts Payable	(5,194)	(424)
Accrued Compensation and Other Current Liabilities	3,947	(3,150)
Net Cash Provided by Operating Activities	26,889	13,975
Cash Flows from Investing Activities:
Purchases of Property and Equipment	(9,099)	(7,149)
Proceeds from Sale of Property and Equipment	0	10
Business Acquisitions, net of cash acquired	(12,932)	(8,306)
Net Cash Used in Investing Activities	(22,031)	(15,445)
Cash Flows from Financing Activities:
(Repayment of) Proceeds from Revolving Credit Facility, net	(42,713)	2,286
Repayments of Term Loan	(1,678)	(1,570)
Issuance of Common Stock, net of direct costs	75,714	503
Repurchase of Common Stock	(2,247)	(437)
Net Cash Provided by Financing Activities	29,076	782
Effect of Exchange Rate Changes on Cash and cash equivalents	(260)	885
Net Increase in Cash and cash equivalents	33,674	197
Cash and cash equivalents at Beginning of Period	1,531	1,396
Cash and cash equivalents at End of Period	35,205	1,593
Supplemental Disclosure of Cash Flow Activity:
Interest	1,652	1,510
Income Taxes, net	1,884	957
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock issued for acquisitions	34,769	145
Assets acquired and liabilities assumed in business combinations:
Balance Sheet Reclassification of Property and Equipment, net to Inventory	737	576
Alliance [Member]
Assets acquired and liabilities assumed in business combinations:
Accrued holdback and contingent consideration related to acquisitions	$ 4,859	$ 518

XML

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Mar. 26, 2022	7,529
Balance at Mar. 26, 2022	$ 3,765	$ 23,900	$ (233)	$ 58,744	$ 86,176
Issuance of Common Stock (in shares)	8
Issuance of Common Stock	$ 3	363	0	0	366
Repurchase of Common Stock (in shares)	(7)
Repurchase of Common Stock	$ (3)	(164)	0	(270)	(437)
Stock-Based Compensation (in shares)	16
Stock-Based Compensation	$ 8	820	0	0	828
Other Comprehensive Income (Loss)	0	0	(453)	0	(453)
Net Income	0	0	0	3,072	3,072
Balance at Jun. 25, 2022	$ 3,773	24,919	(686)	61,546	89,552
Balance (in shares) at Jun. 25, 2022	7,546
Balance (in shares) at Mar. 26, 2022	7,529
Balance at Mar. 26, 2022	$ 3,765	23,900	(233)	58,744	86,176
Net Income					7,030
Balance at Dec. 24, 2022	$ 3,780	27,123	(1,123)	65,504	95,284
Balance (in shares) at Dec. 24, 2022	7,560
Balance (in shares) at Jun. 25, 2022	7,546
Balance at Jun. 25, 2022	$ 3,773	24,919	(686)	61,546	89,552
Issuance of Common Stock (in shares)	3
Issuance of Common Stock	$ 2	141	0	0	143
Repurchase of Common Stock	$ 0	0	0	0	0
Stock-Based Compensation (in shares)	9
Stock-Based Compensation	$ 4	1,110	0	0	1,114
Other Comprehensive Income (Loss)	0	0	(838)	0	(838)
Net Income	0	0	0	2,357	2,357
Balance at Sep. 24, 2022	$ 3,779	26,170	(1,524)	63,903	92,328
Balance (in shares) at Sep. 24, 2022	7,558
Issuance of Common Stock (in shares)	1
Issuance of Common Stock	$ 0	139	0	0	139
Stock-Based Compensation (in shares)	1
Stock-Based Compensation	$ 1	814	0	0	815
Other Comprehensive Income (Loss)	0	0	401	0	401
Net Income	0	0	0	1,601	1,601
Balance at Dec. 24, 2022	$ 3,780	27,123	(1,123)	65,504	95,284
Balance (in shares) at Dec. 24, 2022	7,560
Balance (in shares) at Mar. 25, 2023	7,562
Balance at Mar. 25, 2023	$ 3,781	27,886	(1,200)	69,163	99,630
Issuance of Common Stock (in shares)	82
Issuance of Common Stock	$ 42	6,988	0	0	7,030
Repurchase of Common Stock (in shares)	(3)
Repurchase of Common Stock	$ (2)	(86)	0	(213)	(301)
Stock-Based Compensation (in shares)	2
Stock-Based Compensation	$ 1	929	0	0	930
Other Comprehensive Income (Loss)	0	0	482	0	482
Net Income	0	0	0	2,949	2,949
Balance at Jun. 24, 2023	$ 3,822	35,717	(718)	71,899	110,720
Balance (in shares) at Jun. 24, 2023	7,643
Balance (in shares) at Mar. 25, 2023	7,562
Balance at Mar. 25, 2023	$ 3,781	27,886	(1,200)	69,163	99,630
Net Income					6,757
Balance at Dec. 23, 2023	$ 4,414	140,382	(691)	74,365	218,470
Balance (in shares) at Dec. 23, 2023	8,829
Balance (in shares) at Jun. 24, 2023	7,643
Balance at Jun. 24, 2023	$ 3,822	35,717	(718)	71,899	110,720
Issuance of Common Stock (in shares)	313
Issuance of Common Stock	$ 156	27,967	0	0	28,123
Repurchase of Common Stock (in shares)	(22)
Repurchase of Common Stock	$ (11)	(593)	0	(1,342)	(1,946)
Stock-Based Compensation (in shares)	44
Stock-Based Compensation	$ 22	1,219	0	0	1,241
Other Comprehensive Income (Loss)	0	0	(346)	0	(346)
Net Income	0	0	0	460	460
Balance at Sep. 23, 2023	$ 3,989	64,310	(1,064)	71,017	138,252
Balance (in shares) at Sep. 23, 2023	7,978
Issuance of Common Stock (in shares)	849
Issuance of Common Stock	$ 424	80,229	0	0	80,653
Stock-Based Compensation (in shares)	2
Stock-Based Compensation	$ 1	1,166	0	0	1,167
Other Comprehensive Income (Loss)	0	0	373	0	373
Net Income	0	0	0	3,348	3,348
Balance at Dec. 23, 2023	4,414	140,382	(691)	74,365	218,470
Direct Costs of Stock Offering	$ 0	$ (5,323)	$ 0	$ 0	$ (5,323)
Balance (in shares) at Dec. 23, 2023	8,829

XML

Note 1 - General

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Significant Accounting Policies [Text Block]

NOTE 1 – GENERAL

Description of Business: Transcat, Inc. (“Transcat,” “we,” “us,” “our” or the “Company”) is a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor and rental source for professional grade handheld test, measurement and control instrumentation. The Company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly.

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 25, 2023 (“fiscal year 2023”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2023 filed with the SEC.

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with GAAP requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of major catalogs and intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

Revenue Recognition: Distribution non-rental sales are recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental sales are recognized over time using the output method-time elapsed as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the output method-time elapsed as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

Under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

Revenue recognized from prior period performance obligations for the third quarter of the fiscal year ending March 30, 2024 (“fiscal year 2024”) was immaterial. As of December 23, 2023, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of December 23, 2023 and March 25, 2023 were immaterial. See Note 4 for disaggregated revenue information.

Fair Value of Financial Instruments: Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to the variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs. At each of December 23, 2023 and March 25, 2023, investment assets totaled $0.2 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

Stock-Based Compensation: The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first nine months of fiscal year 2024 and fiscal year 2023, the Company recorded non-cash stock-based compensation cost of $3.3 million and $2.8 million, respectively, in the Consolidated Statements of Income.

Foreign Currency Translation and Transactions: The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in the local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.1 million for each of the first nine months of fiscal year 2024 and fiscal year 2023. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a loss of $0.1 million and a gain of $0.3 million during the first nine months of fiscal years 2024 and 2023, respectively, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On December 23, 2023, the Company had a foreign exchange contract, which matured in January 2024, outstanding in the notional amount of $2.0 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock units using the treasury stock method in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

For the third quarter of fiscal year 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. For the third quarter of fiscal year 2023, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share. For the first nine months of each of fiscal years 2024 and 2023, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Average Shares Outstanding – Basic		8,615		7,559		8,060		7,547
Effect of Dilutive Common Stock Equivalents		137		107		127		97
Average Shares Outstanding – Diluted		8,752		7,666		8,187		7,644
Anti-dilutive Common Stock Equivalents		37		148		46		163

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

	Goodwill						Intangible Assets
	Distribution		Service		Total		Distribution			Service			Total
Net Book Value as of March 25, 2023	$	11,458	$	57,902	$	69,360	$	448		$	13,351		$	13,799
Additions		26,707		9,416		36,123		7,900			3,983			11,883
Amortization		-		-		-		(910	)		(3,317	)		(4,227	)
Currency Translation Adjustment		-		217		217		-			4			4
Net Book Value as of December 23, 2023	$	38,165	$	67,535	$	105,700	$	7,438		$	14,021		$	21,459

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

	(Unaudited)		(Audited)
	December 23,		March 25,
	2023		2023
Current Liabilities:
Accrued Payroll and Employee Benefits	$	4,056	$	3,243
Accrued Incentives		3,095		2,507
Current Portion of Lease Liabilities		2,878		2,333
Accrued Acquisition Holdbacks		2,749		252
Accrued Contingent Consideration		1,029		-
Other Current Liabilities		1,876		1,866
Accrued Compensation and Other Current Liabilities	$	15,683	$	10,201
Non-Current Liabilities:
Postretirement Benefit Obligation	$	1,238	$	1,266
Accrued Acquisition Holdbacks		1,647		-
Accrued Contingent Consideration		2,402		-
Other Non-Current Liabilities		240		168
Other Liabilities	$	5,527	$	1,434

Recently Adopted Accounting Pronouncements: In June 2016, the Financial Accounting Standard Board (“FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The ASU replaces the "incurred loss" model with an "expected credit loss" model that requires entities to estimate an expected lifetime credit loss on financial assets, including trade accounts receivable. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Allowance for credit losses for accounts receivable is the most significant item for the Company under this ASU. The Company adopted ASU 2016-13 effective on March 26, 2023.  The adoption of this standard did not have a material impact on our consolidated financial statements.

XML

Note 2 - Long-term Debt

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Long-Term Debt [Text Block]

NOTE 2 – LONG-TERM DEBT

On July 7, 2021, the Company entered into the Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), that amended and restated in its entirety the Company’s prior credit agreement with M&T.

The Credit Agreement provides for a revolving credit commitment (the “Revolving Credit Commitment”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million.  The Company's 2018 term loan, with an original principal amount of $15.0 million (the "2018 Term Loan"), is also provided for under the Credit Agreement.

The Credit Agreement allows the Company to use up to $50.0 million under the Revolving Credit Commitment for acquisitions in any single fiscal year.  The Credit Agreement restricts the Company's ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the Revolving Credit Commitment.

Under the Credit Agreement, the Company may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

As of December 23, 2023, $80.0 million was available for borrowing under the revolving credit facility.  As of December 23, 2023, there were no amounts outstanding under the revolving credit facility. During the first nine months of fiscal year 2024, $12.9 million was drawn from the revolving credit facility and used for business acquisitions.

As of December 23, 2023, $4.7 million was outstanding on the 2018 Term Loan, of which $2.3 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total amortizing repayments (principal plus interest) of $0.2 million per month through its maturity date in December 2025.

Interest and Other Costs: Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at Transcat’s election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin.  Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon the Company’s calculated leverage ratio. The Company’s interest rate for the revolving credit facility for the first nine months of fiscal year 2024 ranged from 6.4% to 7.1%.  Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

Covenants: The Credit Agreement has certain covenants with which the Company must comply, including a fixed charge ratio covenant, which prohibits the Company's fixed charge ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits the Company's leverage ratio from exceeding 3.00 to 1.00. The Company was in compliance with all loan covenants and requirements during the first nine months of fiscal year 2024. The Company's leverage ratio, as defined in the Credit Agreement, was 0.12 at December 23, 2023, compared with 1.60 at March 25, 2023.

Other Terms: The Company has pledged all of its U.S. tangible and intangible personal property, the equity interests of its U.S.-based subsidiaries, and a majority of the common stock of Transcat Canada Inc. as collateral security for the loans made under the revolving credit facility.

XML

Note 3 - Stock-based Compensation

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

NOTE 3 – STOCK-BASED COMPENSATION

In September 2021, the Transcat, Inc. 2021 Stock Incentive Plan (the “2021 Plan”) was approved by shareholders and became effective. The 2021 Plan replaced the Transcat, Inc. 2003 Incentive Plan (the “2003 Plan”). Shares available for grant under the 2021 Plan include any shares remaining available for issuance under the 2003 Plan and any shares that are subject to outstanding awards under the 2003 Plan that are subsequently canceled, expired, forfeited, or otherwise not issued or are settled in cash. The 2021 Plan provides for, among other awards, grants of restricted stock units and stock options to directors, officers and key employees at the fair market value at the date of grant. At December 23, 2023, 0.6 million shares of common stock were available for future grant under the 2021 Plan.

The Company receives an excess tax benefit related to restricted stock vesting and stock options exercised and redeemed. The discrete tax benefits related to share-based compensation and stock option activity during the first nine months of fiscal year 2024 and fiscal year 2023 were $0.7 million and $0.5 million, respectively.

Restricted Stock Units: The Company grants time-based and performance-based restricted stock units as a component of executive and key employee compensation. Expense for restricted stock unit grants is recognized on a straight-line basis for the service period of the stock award based upon fair value of the award on the date of grant. The fair value of the restricted stock unit grants is the quoted market price for the Company’s common stock on the date of grant. These restricted stock units are either time vested, or vest following the third fiscal year from the date of grant subject to cumulative diluted earnings per share or cumulative adjusted EBITDA targets over the eligible period.

Compensation cost ultimately recognized for performance-based restricted stock units will equal the grant date fair market value of the unit that coincides with the actual outcome of the performance conditions. On an interim basis, the Company records compensation cost based on the estimated level of achievement of the performance conditions. The expense relating to the time vested restricted stock units is recognized on a straight-line basis over the requisite service period for the entire award.

The following table summarizes the non-vested restricted stock units outstanding as of December 23, 2023 (in thousands, except per unit data):

		Total	Grant Date		Estimated
		Number	Fair		Level of
Date	Measurement	of Units	Value		Achievement at
Granted	Period	Outstanding	Per Unit		December 23, 2023
October 2018	October 2018 – September 2028	6	$	20.81	Time Vested
June 2021	June 2021 – March 2024	10	$	53.17	136% of target level
June 2021	June 2021 – March 2024	11	$	53.17	Time Vested
September 2021	September 2021 – September 2024	4	$	67.76	Time Vested
January 2022	January 2022 – March 2024	1	$	90.92	136% of target level
January 2022	January 2022 – March 2024	1	$	90.92	Time Vested
January 2022	January 2022 – January 2025	1	$	90.41	Time Vested
March 2022	March 2022 – March 2025	1	$	76.31	Time Vested
May 2022	May 2022 – March 2025	11	$	63.17	64% of target level
May 2022	May 2022 – March 2025	12	$	63.17	Time Vested
August 2022	August 2022 – August 2025	1	$	78.04	Time Vested
December 2022	December 2022 – December 2025	1	$	81.26	Time Vested
December 2022	December 2022 – December 2025	1	$	67.48	Time Vested
May 2023	May 2023 – March 2026	10	$	89.70	150% of target level
May 2023	May 2023 – March 2026	11	$	89.70	Time Vested
May 2023	May 2023 – May 2026	19	$	89.70	Time Vested
August 2023	August 2023 – August 2024	6	$	90.56	Time Vested
September 2023	September 2023 – September 2024	4	$	109.55	Time Vested

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $2.4 million and $1.7 million in the first nine months of fiscal year 2024 and fiscal year 2023, respectively. As of December 23, 2023, unearned compensation, to be recognized over the grants’ respective service periods, totaled $4.4 million.

Stock Options: The Company grants stock options to employees and directors with an exercise price equal to the quoted market price of the Company’s stock at the date of the grant. The fair value of stock options is estimated using the Black-Scholes option pricing formula that requires assumptions for expected volatility, expected dividends, the risk-free interest rate and the expected term of the option. Expense for stock options is recognized on a straight-line basis over the requisite service period for each award. Options vest either immediately or over a period of up to five years using a straight-line basis and expire either five years or ten years from the date of grant.

We calculate the fair value of the stock options granted using the Black-Scholes model. The following weighted-average assumptions were used to value options granted during the first three and nine months of fiscal year 2024 and fiscal year 2023:

	Third Quarter Ended					Nine Months Ended
	December 23,			December 24,		December 23,			December 24,
	2023			2022		2023			2022
Risk-Free Interest Rate		4.84	%		N/A		4.09	%		2.65	%
Volatility Factor		37.31	%		N/A		37.12	%		37.62	%
Expected Term (in Years)		6.50			N/A		6.30			4.58
Annual Dividend Rate		0.00	%		N/A		0.00	%		0.00	%

We calculate expected volatility for stock options by taking an average of historical volatility over the expected term. The computation of expected term was determined based on safe harbor rules, giving consideration to the contractual terms of the stock-based awards and vesting schedules. The interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield in effect at the time of grant. We assume no expected dividends. Under FASB ASC Topic 718, “Compensation – Stock Compensation”, the Company has elected to account for forfeitures as they occur.

During the first nine months of fiscal year 2024, the Company granted options for 7,000 shares of common stock in the aggregate to Company employees that vest over three years, an option for 10,000 shares of common stock to a Company employee that vests over five years and options for 20,000 shares of common stock (10,000 each) to two Company directors that vest over five years.

During the first nine months of fiscal year 2023, the Company granted options for 46,000 shares of common stock in the aggregate to Company employees that vest over three years and an option for 10,000 shares of common stock to a Company director that vests over five years.

The expense related to all stock option awards was $0.9 million in the first nine months of fiscal year 2024 and $1.1 million in the first nine months of fiscal year 2023.

The following table summarizes the Company’s options as of and for the first nine months ended December 23, 2023 (in thousands, except price per option data and years):

				Weighted		Weighted
				Average		Average
	Number			Exercise		Remaining		Aggregate
	Of			Price Per		Contractual		Intrinsic
	Options			Option		Term (in years)		Value
Outstanding as of March 25, 2023		217		$	56.25
Granted		37		$	93.18
Exercised		(4	)	$	24.30
Forfeited		(5	)	$	68.13
Outstanding as of December 23, 2023		245		$	62.06		6	$	11,180
Exercisable as of December 23, 2023		82		$	41.17		6	$	4,984

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the third quarter of fiscal year 2024 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on December 23, 2023. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

Total unrecognized compensation cost related to non-vested stock options as of December 23, 2023 was $2.4 million, which is expected to be recognized over a period of three years. The aggregate intrinsic value of stock options exercised during the first nine months of fiscal year 2024 was $0.3 million and during the first nine months of fiscal year 2023 was $0.2 million. Cash received from the exercise of options in the first nine months of fiscal year 2024 and fiscal year 2023 was $0.1 million and less than $0.1 million, respectively.

XML

Note 4 - Segment Information

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

NOTE 4 – SEGMENT INFORMATION

The basis for determining our operating segments is the manner in which financial information is used in monitoring our operations. Transcat has two reportable segments: Service and Distribution. Through our Service segment, we offer calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Through our Distribution segment, we sell and rent national and proprietary brand instruments to customers globally. The Company has no inter-segment sales. We believe that reporting performance at the operating income level is the best indicator of segment performance. The following table presents segment and geographic data for the third quarter and first nine months of fiscal year 2024 and fiscal year 2023 (dollars in thousands):

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Revenue:
Service	$	41,509	$	35,977	$	122,793	$	105,120
Distribution		23,657		21,425		65,775		63,382
Total		65,166		57,402		188,568		168,502
Gross Profit:
Service		13,494		10,793		40,549		33,115
Distribution		7,442		5,607		19,222		16,090
Total		20,936		16,400		59,771		49,205
Operating Expenses:
Service (1)		10,528		8,957		33,649		26,240
Distribution (1)		6,114		4,280		15,545		12,572
Total		16,642		13,237		49,194		38,812
Operating Income:
Service		2,966		1,836		6,900		6,875
Distribution		1,328		1,327		3,677		3,518
Total		4,294		3,163		10,577		10,393
Unallocated Amounts:
Interest and Other Expense, net		23		1,039		1,742		1,732
Provision for Income Taxes		923		523		2,078		1,631
Total		946		1,562		3,820		3,363
Net Income	$	3,348	$	1,601	$	6,757	$	7,030
Geographic Data:
Revenues to Unaffiliated Customers (2)
United States (3)	$	59,090	$	51,209	$	170,466	$	151,241
Canada		4,083		4,221		12,226		12,075
Other International		1,993		1,972		5,876		5,186
Total	$	65,166	$	57,402	$	188,568	$	168,502

⁽¹⁾ Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.

⁽²⁾ Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

⁽³⁾ United States includes Puerto Rico.

XML

Note 5 - Business Acquisitions

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Business Combination Disclosure [Text Block]

NOTE 5 – BUSINESS ACQUISITIONS

Axiom: Effective August 8, 2023, Transcat purchased all of the outstanding capital stock of Axiom Test Equipment, Inc. (“Axiom”), a privately-held California rental provider of electronic test equipment to customers across the United States. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Distribution capabilities.

The Axiom goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Axiom acquisition has been allocated to the Distribution segment. Intangible assets related to the Axiom acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to twelve years and are not deductible for tax purposes. Amortization of goodwill related to the Axiom acquisition is not deductible for tax purposes.

The total purchase price for Axiom was approximately $38.6 million and was paid with $10.0 million in cash and the issuance of our common stock valued at $28.6 million. Pursuant to the asset purchase agreement, the Company held back approximately $3.9 million of the purchase price for certain potential post-closing adjustments.

The purchase price allocation is subject to revision based upon our final review of tangible and intangible asset valuation assumptions, working capital adjustments, assets acquired, and liabilities assumed. The amount of goodwill changed since September 23, 2023 due to the finalization of inventory and property and equipment values.  The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Axiom's assets and liabilities acquired on August 8, 2023 (in thousands):

Goodwill		$	26,707
Intangible Assets – Customer Base & Contracts			7,900
			34,607
Plus:	Cash		37
	Accounts Receivable		962
	Inventory		1,796
	Other Current Assets		84
	Property and Equipment		4,965
Less:	Current Liabilities		(631	)
	Deferred Tax Liability		(3,256	)
Total Purchase Price		$	38,564

From the date of acquisition through the end of the third quarter of fiscal year 2024, Axiom has contributed revenue of $4.3 million and operating income of $0.4 million, which includes the negative impact of amortization of the acquired intangible assets.

SteriQual: Effective July 12, 2023, Transcat purchased all of the outstanding capital stock of SteriQual, Inc. (“SteriQual”), a Florida based provider of expert consulting services to pharmaceutical, biopharmaceutical, medical device and diagnostic equipment manufacturers. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The SteriQual goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the SteriQual acquisition has been allocated to the Service segment. Intangible assets related to the SteriQual acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the SteriQual acquisition is not deductible for tax purposes.

The total purchase price for SteriQual was approximately $4.3 million and was paid by the issuance of our common stock.  Pursuant to the asset purchase agreement, the Company held back approximately $0.9 million of the purchase price for certain potential post-closing adjustments. Pursuant to the asset purchase agreement, the purchase price is subject to reduction by $0.5 million if certain revenue targets are not met through July 12, 2024. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. The purchase price was reduced to $3.8 million as of December 23, 2023 as the Company recorded a receivable in the amount of $0.5 million related to the revenue target contingent consideration. This receivable was recognized based on the facts and circumstances at the date of acquisition and is recognized as a component of goodwill and not recorded in the Consolidated Statement of Income. 

The purchase price allocation is subject to revision based upon our final review of intangible asset valuation assumptions, working capital adjustments, assets acquired, and liabilities assumed. The amount of goodwill changed since September 23, 2023 due to the accounts receivable balance as part of the contingent consideration.  The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of SteriQual's assets and liabilities acquired on July 12, 2023 (in thousands):

Goodwill		$	2,163
Intangible Assets – Customer Base & Contracts			1,062
Intangible Assets – Covenant Not to Compete			392
Intangible Assets – Sales Backlog			95
			3,712
Plus:	Accounts Receivable		666
Less:	Current Liabilities		(211	)
	Deferred Tax Liability		(383	)
Total Purchase Price		$	3,784

From the date of acquisition through the end of the third quarter of fiscal year 2024, SteriQual has contributed revenue of $1.9 million and operating income of less than $0.1 million, which includes the negative impact of amortization of the acquired intangible assets.

TIC-MS: Effective March 27, 2023, Transcat purchased all of the outstanding capital stock of TIC-MS, Inc. (“TIC-MS”), a Missouri based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The TIC-MS goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the TIC-MS acquisition has been allocated to the Service segment. Intangible assets related to the TIC-MS acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the TIC-MS acquisition is not deductible for tax purposes.

The total purchase price for TIC-MS was approximately $9.8 million and was paid with $2.9 million in cash, including $0.5 million placed in escrow for contingent consideration, certain post-closing adjustments and indemnification claims, if any, and the issuance of 77,387 shares of our common stock valued at $6.9 million. Pursuant to the asset purchase agreement, the purchase price will be subject to reduction by up to $0.5 million if a key customer relationship is not retained through March 27, 2024. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. As of December 23, 2023, we continued to retain this key customer relationship. As a result, there has not been a receivable recognized relating to the $0.5 million contingent consideration.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of TIC-MS's assets and liabilities acquired on March 27, 2023 (in thousands):

Goodwill		$	7,253
Intangible Assets – Customer Base & Contracts			2,303
Intangible Assets – Covenant Not to Compete			132
			9,688
Plus:	Accounts Receivable		499
	Property and Equipment		356
Less:	Current Liabilities		(128	)
	Deferred Tax Liability		(636	)
Total Purchase Price		$	9,779

From the date of acquisition through the end of the third quarter of fiscal year 2024, TIC-MS has contributed revenue of $2.7 million and operating income of $1.1 million, which includes the negative impact of amortization of the acquired intangible assets.

Elite: Effective February 2, 2023, Transcat acquired substantially all of the assets of Elite Calibration LLC (“Elite”), a California based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that can leverage the Company’s already existing operating infrastructure.

All the goodwill related to the Elite acquisition has been allocated to the Service segment. Amortization of goodwill related to the Elite acquisition is deductible for tax purposes.  The goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition.

The total purchase price for the assets of Elite was approximately $0.9 million, of which $0.8 million was paid in cash. Pursuant to the asset purchase agreement, the Company held back $0.1 million of the purchase price for certain potential post-closing adjustments.  As of December 23, 2023, no amounts have been paid.  The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Elite’s assets and liabilities acquired on February 2, 2023 (in thousands):

Goodwill		$	820
Plus:	Accounts Receivable		62
Total Purchase Price		$	882

Since this operation was integrated immediately into our existing operations, its separate contributed revenue and operating income is undeterminable.

Complete Calibrations: Effective September 28, 2022, Transcat purchased all of the outstanding capital stock of Galium Limited (d/b/a Complete Calibrations) ("Complete Calibrations"), an Irish company.  This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities. 

All the goodwill related to the Complete Calibrations acquisition has been allocated to the Service segment. Amortization of goodwill related to the Complete Calibrations acquisition is not deductible for tax purposes.  The goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition.

The total purchase price paid for Complete Calibrations was approximately $1.2 million in cash.  In connection with this transaction, the Company also entered into a Technology License Agreement with Calibration Robots Limited, an Irish company and related party to Complete Calibrations, for the use of their proprietary robotics in completing calibrations.  The Technology License Agreement includes transactional royalties in the amount of 3 Euros ($3.19) per calibration performed by technology covered under this license agreement, with a royalty term of up to ten years commencing from the earlier of (i) the date on which cumulative revenue earned from technology covered under this license agreement equals 0.75 million Euros ($0.80 million), and (ii) March 28, 2024.  In addition to the transactional royalties, as long as a key employee is employed by the Company, there is an annual royalty fee of 0.1 million Euros ($0.11 million).  For purposes of this paragraph, we used a conversion rate of 1.1014 to convert Euro to U.S. dollar as of December 23, 2023.  As of December 23, 2023, the key employee is still employed by the Company.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Complete Calibrations’ assets and liabilities acquired on September 28, 2022 (in thousands):

Goodwill		$	1,123
Plus:	Cash		10
	Inventory		44
Total Purchase Price		$	1,177

During the first nine months of fiscal year 2024, Complete Calibrations has contributed revenue of $0.3 million and operating loss of less than $0.1 million.

e2b: Effective September 27, 2022, Transcat acquired substantially all of the assets of e2b Calibration (“e2b”), an Ohio based provider of calibration services.  This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities. 

The e2b goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the e2b acquisition has been allocated to the Service segment. Intangible assets related to the e2b acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are deductible for tax purposes. Amortization of goodwill related to the e2b acquisition is deductible for tax purposes.

The total purchase price paid for the assets of e2b was approximately $3.1 million in cash.  Pursuant to the asset purchase agreement, the Company held back $0.9 million of the purchase price in escrow for certain potential post-closing adjustments.  During the third quarter of fiscal year 2023, $0.6 million of the escrow was released to the sellers.  During the third quarter of fiscal year 2024, $0.3 million was released to the sellers.  As of December 23, 2023, there is no money remaining in escrow.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of e2b’s assets and liabilities acquired on September 27, 2022 (in thousands):

Goodwill		$	1,367
Intangible Assets – Customer Base & Contracts			746
Intangible Assets – Covenant Not to Compete			396
			2,509
Plus:	Accounts Receivable		361
	Other Current Assets		24
	Property and Equipment		326
Less:	Current Liabilities		(121	)
Total Purchase Price		$	3,099

 

During the first nine months of fiscal year 2024, e2b has contributed revenue of $2.6 million and operating income of $0.4 million, which includes the negative impact of amortization of the acquired intangible assets.

Alliance: Effective May 31, 2022, Transcat acquired substantially all of the assets of Charlton Jeffmont Inc., Raitz Inc. and Toolroom Calibration Inc. d/b/a Alliance Calibration (“Alliance”), an Ohio based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

The Alliance goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Alliance acquisition has been allocated to the Service segment. Intangible assets related to the Alliance acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are deductible for tax purposes. Amortization of goodwill related to the Alliance acquisition is deductible for tax purposes.

The purchase price for Alliance was approximately $4.7 million and was paid with $4.0 million in cash and the issuance of 2,284 shares of our common stock valued at $0.1 million. Pursuant to the asset purchase agreement, the Company held back $0.5 million of the purchase price for certain potential post-closing adjustments, and the purchase price would have been subject to reduction by $0.5 million if a key customer relationship was not retained. During the first quarter of fiscal year 2024, $0.5 million of the holdback was released to the sellers.

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Alliance’s assets and liabilities acquired on May 31, 2022 (in thousands):

Goodwill		$	1,783
Intangible Assets – Customer Base & Contracts			2,320
Intangible Assets – Covenant Not to Compete			114
			4,217
Plus:	Accounts Receivable		343
	Property and Equipment		170
Less:	Current Liabilities		(27	)
Total Purchase Price		$	4,703

During the first nine months of fiscal year 2024, Alliance has contributed revenue of $2.0 million and operating income of $0.6 million, which includes the negative impact of amortization of the acquired intangible assets.

NEXA: Effective August 31, 2021, Transcat purchased all of the outstanding capital stock of Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management), an Irish company, which owns all of the issued and outstanding capital stock of its U.S.-based subsidiary, Cal OpEx Inc., a Delaware corporation (collectively, “NEXA”). On September 11, 2023, the Company entered into an amendment (the “Amendment”) to a Share Purchase Agreement dated August 31, 2021 (the “Purchase Agreement”) with John Cummins and Ross Lane (the “Sellers”) associated with the Company’s purchase of all of the outstanding capital stock of NEXA. As described below, the Amendment changes the conditions necessary for the Sellers to receive potential earn-out payments, changes the lines of business included in the calculation of earnings before income taxes, depreciation and amortization (“EBITDA”), and changes the outside due date of any potential earn-out payments.

Pursuant to the Purchase Agreement, the Sellers were entitled to potential earn-out payments in an aggregate amount of up to $7.5 million for the calendar years ending December 31, 2022, 2023, 2024, and 2025 (each, an “Earn-Out Year”) if NEXA’s consolidated gross revenue, as defined in the Purchase Agreement, equaled or exceeded 70% of the target revenue specified in the Purchase Agreement and NEXA’s consolidated EBITDA percentage, as defined in the Purchase Agreement, equaled or exceeded 25% for a given earn-out year. The potential earn-out payment of up to $0.4 million for the 2022 Earn-Out Year was not earned under the Purchase Agreement.

Pursuant to the Amendment, the Sellers are now entitled to potential earn-out payments in an aggregate amount of up to $7.1 million for the remaining Earn-Out Years (2023, 2024 and 2025) if NEXA’s consolidated EBITDA, as defined in the Amendment, equals or exceeds 70% of the target EBITDA specified in the Amendment for a given earn-out year. Pursuant to the Amendment, the definition of EBITDA was revised to include EBITDA from the Commissioning, Qualification and Validation business ("CQV") and incremental EBITDA from the SteriQual, Inc. business. The maximum earn-out payment will be received if NEXA’s consolidated EBITDA equals or exceeds 150% of the target EBITDA specified in the Amendment. The earn-out payments, if any, will be paid in shares of common stock, calculated using the volume-weighted average closing price of the common stock for 30 consecutive trading days ending on the trading day that is two days prior to the date the earn-out payment is to be paid (“VWAP”). If the VWAP is less than $45.07 per share, then the Company may pay the earn-out payment in cash in lieu of shares of common stock.

As of March 25, 2023, the estimated fair value for the total earn-out obligations under the Purchase Agreement, classified as Level 3 in the fair value hierarchy, was zero. As of September 23, 2023, the estimated fair value for the total earn-out obligations under the Amendment, classified as Level 3 in the fair value hierarchy, was approximately $2.8 million. This amount was calculated using a Geometric Brownian motion distribution that was then used in a Monte Carlo simulation model. Assumptions used in the Monte Carlo simulation model included: 1) discount rate of 9.00%, 2) risk-free interest rate of 5.00%, 3) asset volatility of 25.00%, and 4) forecasted revenue and EBITDA. This contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. Due to the uncertainty with utilizing these significant unobservable inputs for this Level 3 fair value measurement, materially higher or lower fair value measurements may be recognized at subsequent remeasurement periods. The Company recognized a non-cash expense of $2.8 million, which was recorded in general and administrative expenses in its Consolidated Statement of Income for the quarter ended  September 23, 2023.  As of December 23, 2023, the estimated fair value of the total earn-out obligations under the Amendment was approximately $2.9 million.  The change in accrual is due to the actual results of the 2023 calendar Earn-Out Year and the accretion of the 2024 and 2025 Earn-Out Years.  As a result, the Company recognized a non-cash expense of $0.1 million, which was recorded in general and administrative expenses in its Consolidated Statement of Income for the quarter ended December 23, 2023.  There were no material changes in assumptions that would impact the valuation as of December 23, 2023.

The results of acquired businesses are included in Transcat’s consolidated operating results as of the dates the businesses were acquired. The following unaudited pro forma information presents the Company’s results of operations as if the acquisitions of Axiom, SteriQual, TIC-MS, Elite, Complete Calibrations, e2b and Alliance had occurred at the beginning of fiscal year 2023. The pro forma results do not purport to represent what the Company’s results of operations actually would have been if the transactions had occurred at the beginning of the period presented or what the Company’s operating results will be in future periods.

	(Unaudited)				(Unaudited)
	Third Quarter Ended				Nine Months Ended
(in thousands except per share information)	December 23, 2023		December 24, 2022		December 23, 2023		December 24, 2022
Total Revenue	$	65,166	$	62,868	$	192,613	$	186,276
Net Income	$	3,348	$	1,383	$	6,548	$	5,801
Basic Earnings Per Share	$	0.39	$	0.18	$	0.81	$	0.77
Diluted Earnings Per Share	$	0.38	$	0.18	$	0.80	$	0.76

Certain of the Company’s acquisition agreements include provisions for contingent consideration and other holdback amounts. The Company accrues for contingent consideration and holdback provisions based on their estimated fair value at the date of acquisition and at subsequent remeasurement periods, as applicable.  As of December 23, 2023, $1.0 million contingent consideration and $2.7 million of other holdback amounts unpaid are reflected in current liabilities on the Consolidated Balance Sheets and $2.4 million of contingent consideration and $1.6 million of other holdback amounts unpaid are reflected in other liabilities on the Consolidated Balance Sheets. During the first nine months of fiscal year 2024, $0.8 million of holdback amounts were paid.  During the first nine months of fiscal year 2023, no contingent consideration or other holdback amounts were paid.

During the first nine months of fiscal year 2024 and fiscal year 2023, acquisition costs of $0.7 million and $0.1 million, respectively, were recorded as incurred as general and administrative expenses in the Consolidated Statements of Income.

XML

Note 6 - Stock Offering

9 Months Ended

Dec. 23, 2023

Notes to Financial Statements

Equity [Text Block]

NOTE 6 – STOCK OFFERING

On September 21, 2023, the Company entered into an underwriting agreement with Oppenheimer & Co. Inc., as representative of several underwriters, for the sale of common stock in an underwritten public offering at a public offering price of $95.00 per share (the “Offering”). The Offering closed on September 25, 2023 and the Company sold an aggregate of 847,371 shares in the Offering, which included 110,526 shares issued upon the exercise by the underwriters of their over-allotment option, for total gross proceeds of $80.5 million. Net proceeds received after direct costs in the Offering were $75.2 million. A portion of the net proceeds from this Offering were used to pay off the Revolving Credit Facility in full.

XML

Insider Trading Arrangements

3 Months Ended

Dec. 23, 2023

Insider Trading Arr Line Items

Material Terms of Trading Arrangement [Text Block]

PART II. OTHER INFORMATION

Rule 10b5-1 Arrangement Adopted [Flag]

false

Non-Rule 10b5-1 Arrangement Adopted [Flag]

false

Rule 10b5-1 Arrangement Terminated [Flag]

false

Non-Rule 10b5-1 Arrangement Terminated [Flag]

false

XML

Significant Accounting Policies (Policies)

9 Months Ended

Dec. 23, 2023

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 25, 2023 (“fiscal year 2023”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2023 filed with the SEC.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with GAAP requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of major catalogs and intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

Revenue [Policy Text Block]

Revenue Recognition: Distribution non-rental sales are recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental sales are recognized over time using the output method-time elapsed as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the output method-time elapsed as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

Under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

Revenue recognized from prior period performance obligations for the third quarter of the fiscal year ending March 30, 2024 (“fiscal year 2024”) was immaterial. As of December 23, 2023, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of December 23, 2023 and March 25, 2023 were immaterial. See Note 4 for disaggregated revenue information.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments: Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to the variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs. At each of December 23, 2023 and March 25, 2023, investment assets totaled $0.2 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

Share-Based Payment Arrangement [Policy Text Block]

Stock-Based Compensation: The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first nine months of fiscal year 2024 and fiscal year 2023, the Company recorded non-cash stock-based compensation cost of $3.3 million and $2.8 million, respectively, in the Consolidated Statements of Income.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Foreign Currency Translation and Transactions: The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in the local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.1 million for each of the first nine months of fiscal year 2024 and fiscal year 2023. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a loss of $0.1 million and a gain of $0.3 million during the first nine months of fiscal years 2024 and 2023, respectively, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On December 23, 2023, the Company had a foreign exchange contract, which matured in January 2024, outstanding in the notional amount of $2.0 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock units using the treasury stock method in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

For the third quarter of fiscal year 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. For the third quarter of fiscal year 2023, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share. For the first nine months of each of fiscal years 2024 and 2023, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Average Shares Outstanding – Basic		8,615		7,559		8,060		7,547
Effect of Dilutive Common Stock Equivalents		137		107		127		97
Average Shares Outstanding – Diluted		8,752		7,666		8,187		7,644
Anti-dilutive Common Stock Equivalents		37		148		46		163

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

	Goodwill						Intangible Assets
	Distribution		Service		Total		Distribution			Service			Total
Net Book Value as of March 25, 2023	$	11,458	$	57,902	$	69,360	$	448		$	13,351		$	13,799
Additions		26,707		9,416		36,123		7,900			3,983			11,883
Amortization		-		-		-		(910	)		(3,317	)		(4,227	)
Currency Translation Adjustment		-		217		217		-			4			4
Net Book Value as of December 23, 2023	$	38,165	$	67,535	$	105,700	$	7,438		$	14,021		$	21,459

Other Liabilities Policy [Policy Text Block]

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

	(Unaudited)		(Audited)
	December 23,		March 25,
	2023		2023
Current Liabilities:
Accrued Payroll and Employee Benefits	$	4,056	$	3,243
Accrued Incentives		3,095		2,507
Current Portion of Lease Liabilities		2,878		2,333
Accrued Acquisition Holdbacks		2,749		252
Accrued Contingent Consideration		1,029		-
Other Current Liabilities		1,876		1,866
Accrued Compensation and Other Current Liabilities	$	15,683	$	10,201
Non-Current Liabilities:
Postretirement Benefit Obligation	$	1,238	$	1,266
Accrued Acquisition Holdbacks		1,647		-
Accrued Contingent Consideration		2,402		-
Other Non-Current Liabilities		240		168
Other Liabilities	$	5,527	$	1,434

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Pronouncements: In June 2016, the Financial Accounting Standard Board (“FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The ASU replaces the "incurred loss" model with an "expected credit loss" model that requires entities to estimate an expected lifetime credit loss on financial assets, including trade accounts receivable. The ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Allowance for credit losses for accounts receivable is the most significant item for the Company under this ASU. The Company adopted ASU 2016-13 effective on March 26, 2023.  The adoption of this standard did not have a material impact on our consolidated financial statements.

XML

Note 1 - General (Tables)

9 Months Ended

Dec. 23, 2023

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Average Shares Outstanding – Basic		8,615		7,559		8,060		7,547
Effect of Dilutive Common Stock Equivalents		137		107		127		97
Average Shares Outstanding – Diluted		8,752		7,666		8,187		7,644
Anti-dilutive Common Stock Equivalents		37		148		46		163

Schedule of Intangible Assets and Goodwill [Table Text Block]

	Goodwill						Intangible Assets
	Distribution		Service		Total		Distribution			Service			Total
Net Book Value as of March 25, 2023	$	11,458	$	57,902	$	69,360	$	448		$	13,351		$	13,799
Additions		26,707		9,416		36,123		7,900			3,983			11,883
Amortization		-		-		-		(910	)		(3,317	)		(4,227	)
Currency Translation Adjustment		-		217		217		-			4			4
Net Book Value as of December 23, 2023	$	38,165	$	67,535	$	105,700	$	7,438		$	14,021		$	21,459

Schedule of Accrued Liabilities [Table Text Block]

	(Unaudited)		(Audited)
	December 23,		March 25,
	2023		2023
Current Liabilities:
Accrued Payroll and Employee Benefits	$	4,056	$	3,243
Accrued Incentives		3,095		2,507
Current Portion of Lease Liabilities		2,878		2,333
Accrued Acquisition Holdbacks		2,749		252
Accrued Contingent Consideration		1,029		-
Other Current Liabilities		1,876		1,866
Accrued Compensation and Other Current Liabilities	$	15,683	$	10,201
Non-Current Liabilities:
Postretirement Benefit Obligation	$	1,238	$	1,266
Accrued Acquisition Holdbacks		1,647		-
Accrued Contingent Consideration		2,402		-
Other Non-Current Liabilities		240		168
Other Liabilities	$	5,527	$	1,434

XML

Note 3 - Stock-based Compensation (Tables)

9 Months Ended

Dec. 23, 2023

Notes Tables

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

		Total	Grant Date		Estimated
		Number	Fair		Level of
Date	Measurement	of Units	Value		Achievement at
Granted	Period	Outstanding	Per Unit		December 23, 2023
October 2018	October 2018 – September 2028	6	$	20.81	Time Vested
June 2021	June 2021 – March 2024	10	$	53.17	136% of target level
June 2021	June 2021 – March 2024	11	$	53.17	Time Vested
September 2021	September 2021 – September 2024	4	$	67.76	Time Vested
January 2022	January 2022 – March 2024	1	$	90.92	136% of target level
January 2022	January 2022 – March 2024	1	$	90.92	Time Vested
January 2022	January 2022 – January 2025	1	$	90.41	Time Vested
March 2022	March 2022 – March 2025	1	$	76.31	Time Vested
May 2022	May 2022 – March 2025	11	$	63.17	64% of target level
May 2022	May 2022 – March 2025	12	$	63.17	Time Vested
August 2022	August 2022 – August 2025	1	$	78.04	Time Vested
December 2022	December 2022 – December 2025	1	$	81.26	Time Vested
December 2022	December 2022 – December 2025	1	$	67.48	Time Vested
May 2023	May 2023 – March 2026	10	$	89.70	150% of target level
May 2023	May 2023 – March 2026	11	$	89.70	Time Vested
May 2023	May 2023 – May 2026	19	$	89.70	Time Vested
August 2023	August 2023 – August 2024	6	$	90.56	Time Vested
September 2023	September 2023 – September 2024	4	$	109.55	Time Vested

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Third Quarter Ended					Nine Months Ended
	December 23,			December 24,		December 23,			December 24,
	2023			2022		2023			2022
Risk-Free Interest Rate		4.84	%		N/A		4.09	%		2.65	%
Volatility Factor		37.31	%		N/A		37.12	%		37.62	%
Expected Term (in Years)		6.50			N/A		6.30			4.58
Annual Dividend Rate		0.00	%		N/A		0.00	%		0.00	%

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

				Weighted		Weighted
				Average		Average
	Number			Exercise		Remaining		Aggregate
	Of			Price Per		Contractual		Intrinsic
	Options			Option		Term (in years)		Value
Outstanding as of March 25, 2023		217		$	56.25
Granted		37		$	93.18
Exercised		(4	)	$	24.30
Forfeited		(5	)	$	68.13
Outstanding as of December 23, 2023		245		$	62.06		6	$	11,180
Exercisable as of December 23, 2023		82		$	41.17		6	$	4,984

XML

Note 4 - Segment Information (Tables)

9 Months Ended

Dec. 23, 2023

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Third Quarter Ended				Nine Months Ended
	December 23,		December 24,		December 23,		December 24,
	2023		2022		2023		2022
Revenue:
Service	$	41,509	$	35,977	$	122,793	$	105,120
Distribution		23,657		21,425		65,775		63,382
Total		65,166		57,402		188,568		168,502
Gross Profit:
Service		13,494		10,793		40,549		33,115
Distribution		7,442		5,607		19,222		16,090
Total		20,936		16,400		59,771		49,205
Operating Expenses:
Service (1)		10,528		8,957		33,649		26,240
Distribution (1)		6,114		4,280		15,545		12,572
Total		16,642		13,237		49,194		38,812
Operating Income:
Service		2,966		1,836		6,900		6,875
Distribution		1,328		1,327		3,677		3,518
Total		4,294		3,163		10,577		10,393
Unallocated Amounts:
Interest and Other Expense, net		23		1,039		1,742		1,732
Provision for Income Taxes		923		523		2,078		1,631
Total		946		1,562		3,820		3,363
Net Income	$	3,348	$	1,601	$	6,757	$	7,030
Geographic Data:
Revenues to Unaffiliated Customers (2)
United States (3)	$	59,090	$	51,209	$	170,466	$	151,241
Canada		4,083		4,221		12,226		12,075
Other International		1,993		1,972		5,876		5,186
Total	$	65,166	$	57,402	$	188,568	$	168,502

XML

Note 5 - Business Acquisitions (Tables)

9 Months Ended

Dec. 23, 2023

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Goodwill		$	26,707
Intangible Assets – Customer Base & Contracts			7,900
			34,607
Plus:	Cash		37
	Accounts Receivable		962
	Inventory		1,796
	Other Current Assets		84
	Property and Equipment		4,965
Less:	Current Liabilities		(631	)
	Deferred Tax Liability		(3,256	)
Total Purchase Price		$	38,564

Goodwill		$	2,163
Intangible Assets – Customer Base & Contracts			1,062
Intangible Assets – Covenant Not to Compete			392
Intangible Assets – Sales Backlog			95
			3,712
Plus:	Accounts Receivable		666
Less:	Current Liabilities		(211	)
	Deferred Tax Liability		(383	)
Total Purchase Price		$	3,784

Goodwill		$	7,253
Intangible Assets – Customer Base & Contracts			2,303
Intangible Assets – Covenant Not to Compete			132
			9,688
Plus:	Accounts Receivable		499
	Property and Equipment		356
Less:	Current Liabilities		(128	)
	Deferred Tax Liability		(636	)
Total Purchase Price		$	9,779

Goodwill		$	820
Plus:	Accounts Receivable		62
Total Purchase Price		$	882

Goodwill		$	1,123
Plus:	Cash		10
	Inventory		44
Total Purchase Price		$	1,177

Goodwill		$	1,367
Intangible Assets – Customer Base & Contracts			746
Intangible Assets – Covenant Not to Compete			396
			2,509
Plus:	Accounts Receivable		361
	Other Current Assets		24
	Property and Equipment		326
Less:	Current Liabilities		(121	)
Total Purchase Price		$	3,099

Goodwill		$	1,783
Intangible Assets – Customer Base & Contracts			2,320
Intangible Assets – Covenant Not to Compete			114
			4,217
Plus:	Accounts Receivable		343
	Property and Equipment		170
Less:	Current Liabilities		(27	)
Total Purchase Price		$	4,703

Business Acquisition, Pro Forma Information [Table Text Block]

	(Unaudited)				(Unaudited)
	Third Quarter Ended				Nine Months Ended
(in thousands except per share information)	December 23, 2023		December 24, 2022		December 23, 2023		December 24, 2022
Total Revenue	$	65,166	$	62,868	$	192,613	$	186,276
Net Income	$	3,348	$	1,383	$	6,548	$	5,801
Basic Earnings Per Share	$	0.39	$	0.18	$	0.81	$	0.77
Diluted Earnings Per Share	$	0.38	$	0.18	$	0.80	$	0.76

XML

Note 1 - General (Details Textual) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Dec. 23, 2023	Dec. 23, 2023	Dec. 24, 2022	Sep. 30, 2023	Mar. 25, 2023
Investments	$ 0.2	$ 0.2			$ 0.2
Share-Based Payment Arrangement, Expense		3.3	$ 2.8
Realized Gain (Loss), Foreign Currency Transaction, before Tax		0.1
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax		$ 0.1	$ 0.3
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.5	$ 0.5		$ 0.5	$ 0.5
Dilutive Securities, Effect Per Share on Earnings (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Foreign Exchange Contract [Member]
Derivative Asset, Notional Amount	$ 2.0	$ 2.0

XML

Note 1 - General - Computation of Basic and Diluted Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 23, 2023	Dec. 24, 2022	Dec. 23, 2023	Dec. 24, 2022
Average Shares Outstanding – Basic (in shares)	8,615	7,559	8,060	7,547
Effect of Dilutive Common Stock Equivalents (in shares)	137	107	127	97
Average Shares Outstanding – Diluted (in shares)	8,752	7,666	8,187	7,644
Anti-dilutive Common Stock Equivalents (in shares)	37	148	46	163

XML

Note 1 - General - Summary of Changes in Goodwill and Intangible Assets (Details) $ in Thousands	9 Months Ended
	Dec. 23, 2023 USD ($)
Net Book Value, goodwill	$ 69,360
Net Book Value, intangible assets	13,799
Additions, goodwill	36,123
Additions, intangible assets	11,883
Amortization, goodwill	0
Amortization, intangible assets	(4,227)
Currency Translation Adjustment, goodwill	217
Currency Translation Adjustment, intangible assets	4
Net Book Value, goodwill	105,700
Net Book Value, intangible assets	21,459
Distribution Segment [Member]
Net Book Value, goodwill	11,458
Net Book Value, intangible assets	448
Additions, goodwill	26,707
Additions, intangible assets	7,900
Amortization, goodwill	0
Amortization, intangible assets	(910)
Currency Translation Adjustment, goodwill	0
Currency Translation Adjustment, intangible assets	0
Net Book Value, goodwill	38,165
Net Book Value, intangible assets	7,438
Service Segment [Member]
Net Book Value, goodwill	57,902
Net Book Value, intangible assets	13,351
Additions, goodwill	9,416
Additions, intangible assets	3,983
Amortization, goodwill	0
Amortization, intangible assets	(3,317)
Currency Translation Adjustment, goodwill	217
Currency Translation Adjustment, intangible assets	4
Net Book Value, goodwill	67,535
Net Book Value, intangible assets	$ 14,021

XML

Note 1 - General - Summary of Liabilities Current and Non-current (Details) - USD ($) $ in Thousands	Dec. 23, 2023	Mar. 25, 2023
Accrued Payroll and Employee Benefits	$ 4,056	$ 3,243
Accrued Incentives	3,095	2,507
Current Portion of Lease Liabilities	2,878	2,333
Accrued Acquisition Holdbacks	2,749	252
Accrued Contingent Consideration	1,029	0
Other Current Liabilities	1,876	1,866
Accrued Compensation and Other Current Liabilities	15,683	10,201
Postretirement Benefit Obligation	1,238	1,266
Accrued Acquisition Holdbacks	1,647	0
Accrued Contingent Consideration	2,402	0
Other Non-Current Liabilities	240	168
Other Liabilities	$ 5,527	$ 1,434

XML

Note 2 - Long-term Debt (Details Textual) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 23, 2023 USD ($)	Mar. 25, 2023 USD ($)	Jun. 24, 2023 USD ($)	Sep. 26, 2021	Jul. 07, 2021 USD ($)	May 18, 2020 USD ($)
Long-Term Debt, Current Maturities	$ 2,316	$ 2,248
The 2018 Term Loan [Member]
Debt Instrument, Face Amount					$ 15,000
Long-Term Debt, Current Maturities	2,300
Debt Instrument, Periodic Payment, Total	200
Debt Instrument, Interest Rate, Stated Percentage				3.90%
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity					80,000
Debt Instrument, Covenant, Restriction to Repurchase Shares and Pay Dividends, Aggregate					10,000	$ 25,000
Line of Credit Facility, Current Borrowing Capacity	80,000
Long-Term Line of Credit	0
Business Acquisition, Transaction Costs	12,900
Long-Term Debt	$ 4,700
LIBOR Floor	0.25%
Debt Instrument, Covenant, Maximum Fixed Charge Ratio	1.15
Debt Instrument, Covenant, Maximum Total Leverage Ratio	3
Total Leverage Ratio	0.12	1.6
Revolving Credit Facility [Member] | Maximum [Member]
Debt Instrument, Permitted Acquisition, Aggregate Purchase Price			$ 50,000
Debt Instrument, Permitted Acquisition, Additional Aggregate Purchase Price			$ 40,000
Debt Instrument, Interest Rate, Effective Percentage	7.10%
Revolving Credit Facility [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage	6.40%
Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 10,000

XML

Note 3 - Stock-based Compensation (Details Textual) - USD ($) Pure in Thousands, $ in Millions	3 Months Ended	9 Months Ended
	Dec. 23, 2023	Dec. 23, 2023	Dec. 24, 2022
Share-Based Payment Arrangement, Expense, Tax Benefit		$ 0.7	$ 0.5
Share-Based Payment Arrangement, Expense		$ 3.3	2.8
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		37,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value		$ 0.3	0.2
Proceeds from Stock Options Exercised		$ 0.1	$ 0.1
Board of Directors Member [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		5 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		10,000
Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		5 years	5 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		20,000	10,000
Each Board of Directors Member [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		10,000
Performance-based Restricted Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		3 years
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense		$ 2.4	$ 1.7
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 4.4	$ 4.4
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		5 years	3 years
Share-Based Payment Arrangement, Expense		$ 0.9	$ 1.1
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 2.4	$ 2.4
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%	0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)			46,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		3 years
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		3 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		7,000
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)		5 years
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)		10 years
The 2021 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)	600,000	600,000

XML

Note 3 - Stock-based Compensation - Summary of Non-vested Restricted Stock Units (Details) - Performance-based Restricted Stock Units [Member] shares in Thousands	Dec. 23, 2023 $ / shares shares
October 2018 [Member]
Total number of units outstanding (in shares) | shares	6
Grant date fair value per unit (in dollars per share) | $ / shares	$ 20.81
July 2020 [Member]
Total number of units outstanding (in shares) | shares	10
Grant date fair value per unit (in dollars per share) | $ / shares	$ 53.17
September 2020, First Issuance [Member]
Total number of units outstanding (in shares) | shares	11
Grant date fair value per unit (in dollars per share) | $ / shares	$ 53.17
September 2020, Second Issuance [Member]
Total number of units outstanding (in shares) | shares	4
Grant date fair value per unit (in dollars per share) | $ / shares	$ 67.76
September 2020, Third Issuance [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 90.92
June 2021, First Issuance [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 90.92
June 2021, Second Issuance [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 90.41
September 2021 [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 76.31
January 2022, First Issuance [Member]
Total number of units outstanding (in shares) | shares	11
Grant date fair value per unit (in dollars per share) | $ / shares	$ 63.17
January 2022, Second Issuance [Member]
Total number of units outstanding (in shares) | shares	12
Grant date fair value per unit (in dollars per share) | $ / shares	$ 63.17
January 2022, Third Issuance [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 78.04
March 2022 [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 81.26
May 2022, First Issuance [Member]
Total number of units outstanding (in shares) | shares	1
Grant date fair value per unit (in dollars per share) | $ / shares	$ 67.48
May 2022, Second Issuance [Member]
Total number of units outstanding (in shares) | shares	10
Grant date fair value per unit (in dollars per share) | $ / shares	$ 89.7
August 2022 Issuance [Member]
Total number of units outstanding (in shares) | shares	11
Grant date fair value per unit (in dollars per share) | $ / shares	$ 89.7
September 2022 [Member]
Total number of units outstanding (in shares) | shares	19
Grant date fair value per unit (in dollars per share) | $ / shares	$ 89.7
December 2022 First Issuance [Member]
Total number of units outstanding (in shares) | shares	6
Grant date fair value per unit (in dollars per share) | $ / shares	$ 90.56
December 2022 Second Issuance [Member]
Total number of units outstanding (in shares) | shares	4
Grant date fair value per unit (in dollars per share) | $ / shares	$ 109.55

XML

Note 3 - Stock-based Compensation - Weighted Average Assumptions (Details)	3 Months Ended	9 Months Ended
	Dec. 23, 2023	Dec. 23, 2023	Dec. 24, 2022
Annual Dividend Rate		0.00%
Share-Based Payment Arrangement, Option [Member]
Risk-Free Interest Rate	4.84%	4.09%	2.65%
Volatility Factor	37.31%	37.12%	37.62%
Expected Term (in Years) (Year)	6 years 6 months	6 years 3 months 18 days	4 years 6 months 29 days
Annual Dividend Rate	0.00%	0.00%	0.00%

XML

Note 3 - Stock-based Compensation - Summary of Options (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Dec. 23, 2023 USD ($) $ / shares shares
Outstanding, number of options (in shares) | shares	217
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 56.25
Granted, number of options (in shares) | shares	37
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 93.18
Exercised, number of options (in shares) | shares	(4)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 24.3
Forfeited, number of options (in shares) | shares	(5)
Forfeited, weighted average exercise price (in dollars per share) | $ / shares	$ 68.13
Outstanding, number of options (in shares) | shares	245
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 62.06
Outstanding, weighted average remaining contractual term (Year)	6 years
Oustanding, aggregate intrinsic value | $	$ 11,180
Exercisable, number of options (in shares) | shares	82
Exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 41.17
Exercisable, weighted average remaining contractual term (Year)	6 years
Exercisable, aggregate intrinsic value | $	$ 4,984

XML

Note 4 - Segment Information (Details Textual)	9 Months Ended
	Dec. 23, 2023
Number of Reportable Segments	2

XML

Note 4 - Segment Information - Segment and Geographic Data (Details) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Dec. 23, 2023	Sep. 23, 2023	Jun. 24, 2023	Dec. 24, 2022	Sep. 24, 2022	Jun. 25, 2022	Dec. 23, 2023	Dec. 24, 2022
Revenue	[1]	$ 65,166			$ 57,402			$ 188,568	$ 168,502
Gross Profit		20,936			16,400			59,771	49,205
Operating Expenses		16,642			13,237			49,194	38,812
Operating Income		4,294			3,163			10,577	10,393
Interest and Other Expense, net		23			1,039			1,742	1,732
Provision for Income Taxes		923			523			2,078	1,631
Total		946			1,562			3,820	3,363
Net Income		3,348	$ 460	$ 2,949	1,601	$ 2,357	$ 3,072	6,757	7,030
UNITED STATES
Revenue	[1],[2]	59,090			51,209			170,466	151,241
CANADA
Revenue	[1]	4,083			4,221			12,226	12,075
Other International [Member]
Revenue	[1]	1,993			1,972			5,876	5,186
Service Segment [Member] | Operating Segments [Member]
Revenue		41,509			35,977			122,793	105,120
Gross Profit		13,494			10,793			40,549	33,115
Operating Expenses	[3]	10,528			8,957			33,649	26,240
Operating Income		2,966			1,836			6,900	6,875
Distribution Segment [Member] | Operating Segments [Member]
Revenue		23,657			21,425			65,775	63,382
Gross Profit		7,442			5,607			19,222	16,090
Operating Expenses	[3]	6,114			4,280			15,545	12,572
Operating Income		$ 1,328			$ 1,327			$ 3,677	$ 3,518

[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

[2] United States includes Puerto Rico.

[3] Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.

XML

Note 5 - Business Acquisitions (Details Textual) $ / shares in Units, € in Thousands, $ in Thousands											3 Months Ended			6 Months Ended	9 Months Ended
		Dec. 23, 2023 USD ($)	Aug. 08, 2023 USD ($)	Jul. 12, 2023 USD ($)	Mar. 27, 2023 USD ($) shares	Feb. 02, 2023 USD ($)	Sep. 28, 2022 USD ($)	Sep. 28, 2022 EUR (€)	Sep. 27, 2022 USD ($)	May 31, 2022 USD ($) shares	Dec. 23, 2023 USD ($)	Jun. 24, 2023 USD ($)	Dec. 24, 2022 USD ($)	Sep. 23, 2023 USD ($) $ / shares	Dec. 31, 2023 USD ($)	Dec. 23, 2023 USD ($)	Dec. 24, 2022 USD ($)	Sep. 23, 2022 USD ($)	Aug. 31, 2021 USD ($)
Revenues	[1]										$ 65,166		$ 57,402			$ 188,568	$ 168,502
Operating Income (Loss)											4,294		3,163			10,577	10,393
Share-Based Payment Arrangement, Expense																3,300	2,800
Other Expense [Member]
Payments for Other Holdbacks																800	0
General and Administrative Expense [Member]
Business Combination, Acquisition Related Costs																700	$ 100
Current Liabilities [Member]
Business Combination, Contingent Consideration, Liability, Current		$ 1,000									1,000					1,000
Unpaid Amounts for Other Holdbacks		2,700									2,700					2,700
Other Liabilities [Member]
Business Combination, Contingent Consideration, Liability, Current		2,400									2,400					2,400
Unpaid Amounts for Other Holdbacks		$ 1,600									$ 1,600					1,600
Complete Calibrations [Member]
Revenues																$ 300
Foreign Currency Exchange Rate, Translation		1.1014									1.1014					1.1014
Operating Income (Loss)																$ 100
Axiom [Member]
Business Combination, Consideration Transferred			$ 38,600
Payments to Acquire Businesses, Gross			10,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			28,600
Business Combination, Payment Withheld for Potential Post-closing Adjustments			$ 3,900
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual											$ 4,300
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual											400
SteriQual, Inc. [Member]
Business Combination, Consideration Transferred		$ 3,800		$ 4,300
Business Combination, Consideration Held Back				900
Business Combination, Consideration Subject to Reduction				$ 500	$ 500
Revenues											1,900
Cash Out of Escrow Account											100
TIC-MS, Inc. [Member]
Business Combination, Consideration Transferred					9,800
Payments to Acquire Businesses, Gross					2,900
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable					$ 6,900
Revenues											2,700
Cash Out of Escrow Account											1,100
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)					15 years
Escrow Deposit					$ 500
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares					77,387
TIC-MS, Inc. [Member] | Scenario, Adjustment [Member]
Business Combination, Potential Purchase Price Adjustment for Failure to Retain Key Customer Relationships					$ 500
Elite [Member]
Business Combination, Consideration Transferred						$ 900
Payments to Acquire Businesses, Gross						800
Business Combination, Payment Withheld for Potential Post-closing Adjustments						$ 100
Complete Calibrations [Member]
Payments to Acquire Businesses, Gross							$ 1,200
Complete Calibrations [Member] | Technology License Agreement [Member]
Royalties Per Technology Calibration							$ 3,190	€ 3,000
Technology License Agreement, Term (Year)							10 years	10 years
Cumulative License Revenue							$ 800	€ 750
Annual Royalty Fee, Amount							$ 110	€ 100
e2b [Member]
Payments to Acquire Businesses, Gross									$ 3,100
Business Combination, Consideration Held Back									$ 900
Revenues																2,600
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)									15 years
Escrow Deposit		0									0					0
Operating Income (Loss)																400
Escrow Released to Sellers											300		$ 600
Alliance [Member]
Business Combination, Consideration Transferred										$ 4,700
Payments to Acquire Businesses, Gross										4,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable										100
Business Combination, Consideration Held Back										500
Business Combination, Consideration Subject to Reduction										$ 500		$ 500
Revenues																2,000
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)										15 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares										2,284
Operating Income (Loss)																600
NEXA [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High														$ 7,100				$ 400	$ 7,500
Business Combination, Contingent Consideration, Maximum Price Per Share for Cash Earn Out Payment (in dollars per share) | $ / shares														$ 45.07
Business Combination, Contingent Consideration, Liability		$ 2,900									$ 2,900			$ 2,800		$ 2,900
Share-Based Payment Arrangement, Expense														$ 2,800	$ 100
NEXA [Member] | Measurement Input, Cost to Sell [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input														9
NEXA [Member] | Measurement Input, Risk Free Interest Rate [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input														5
NEXA [Member] | Measurement Input, Price Volatility [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input														25

[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

XML

Note 5 - Business Acquisitions - Summary of Purchase Price Allocation (Details) - USD ($) $ in Thousands	Dec. 23, 2023	Aug. 08, 2023	Jul. 12, 2023	Mar. 27, 2023	Mar. 25, 2023	Feb. 02, 2023	Sep. 28, 2022	Sep. 27, 2022	May 31, 2022
Goodwill	$ 105,700				$ 69,360
Axiom [Member]
Goodwill		$ 26,707
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes		34,607
Cash		37
Accounts Receivable		962
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		1,796
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		(84)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		4,965
Current Liabilities		(631)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		(3,256)
Total Purchase Price		38,564
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		(3,256)
Property and Equipment		4,965
Other Current Assets		84
Axiom [Member] | Customer-Related Intangible Assets [Member]
Intangible Assets		$ 7,900
SteriQual, Inc. [Member]
Goodwill			$ 2,163
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes			3,712
Accounts Receivable			666
Current Liabilities			(211)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities			(383)
Total Purchase Price			3,784
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities			(383)
SteriQual, Inc. [Member] | Customer-Related Intangible Assets [Member]
Intangible Assets			1,062
SteriQual, Inc. [Member] | Noncompete Agreements [Member]
Intangible Assets			392
SteriQual, Inc. [Member] | Sales Backlog [Member]
Intangible Assets			$ 95
TIC-MS, Inc. [Member]
Goodwill				$ 7,253
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes				9,688
Accounts Receivable				499
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment				356
Current Liabilities				(128)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities				(636)
Total Purchase Price				9,779
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities				(636)
Property and Equipment				356
TIC-MS, Inc. [Member] | Customer-Related Intangible Assets [Member]
Intangible Assets				2,303
TIC-MS, Inc. [Member] | Noncompete Agreements [Member]
Intangible Assets				$ 132
Elite [Member]
Goodwill						$ 820
Accounts Receivable						62
Total Purchase Price						$ 882
Complete Calibrations [Member]
Goodwill							$ 1,123
Cash							10
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory							44
Total Purchase Price							$ 1,177
e2b [Member]
Goodwill								$ 1,367
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes								2,509
Accounts Receivable								361
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other								(24)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment								326
Current Liabilities								(121)
Total Purchase Price								3,099
Property and Equipment								326
Other Current Assets								24
e2b [Member] | Customer-Related Intangible Assets [Member]
Intangible Assets								746
e2b [Member] | Noncompete Agreements [Member]
Intangible Assets								$ 396
Alliance [Member]
Goodwill									$ 1,783
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes									4,217
Accounts Receivable									343
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment									170
Current Liabilities									(27)
Total Purchase Price									4,703
Property and Equipment									170
Alliance [Member] | Customer-Related Intangible Assets [Member]
Intangible Assets									2,320
Alliance [Member] | Noncompete Agreements [Member]
Intangible Assets									$ 114

XML

Note 5 - Business Acquisitions - Pro Forma Results (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 23, 2023	Dec. 24, 2022	Dec. 23, 2023	Dec. 24, 2022
Total Revenue	$ 65,166	$ 62,868	$ 192,613	$ 186,276
Net Income	$ 3,348	$ 1,383	$ 6,548	$ 5,801
Basic Earnings Per Share (in dollars per share)	$ 0.39	$ 0.18	$ 0.81	$ 0.77
Diluted Earnings Per Share (in dollars per share)	$ 0.38	$ 0.18	$ 0.8	$ 0.76

XML

Note 6 - Stock Offering (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
	Sep. 25, 2023	Dec. 23, 2023	Dec. 24, 2022	Mar. 25, 2023
Common Stock, Shares, Issued (in shares)		8,828,515		7,562,604
Proceeds from Issuance of Common Stock	$ 80,500
Proceeds From Issuance of Common Stock, Net	$ 75,200	$ 75,714	$ 503
The Offering [Member]
Shares Issued, Price Per Share (in dollars per share)	$ 95
Common Stock, Shares, Issued (in shares)	847,371
Shares, Issued (in shares)	110,526